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INTRODUCTION 
Living organisms require a continual input of free energy to maintain the Jiving 
state. About 95% of the energy required is obtained from a coupling reaction known as 
oxidative phosphorylation which takes place in the inner mitochondrial membrane. 
Oxidative phosphorylation is carried out by the mitochondrial respiratory ( electron 
transfer) chain and ATP synthase. The energy released from the oxidation ofNADH or 
succinate by the mitochondrial respiratory chain is conserved as an electrochemical proton 
gradient (AµH+), which is then utilized by an ATP synthase complex tQ synthesize 
adenosine triphosphate (ATP). The electrochemical proton gradient, also known as 
protonmotive force, consists of two components, a proton concentration gradient (ApH) 
and a membrane electrical potential (A\11) (1). 
The mitochondrial respiratory chain is composed of four electron transfer 
complexes: NADH-ubiquinone reductase (NQR), succinate-ubiquinone reductase (SQR), 
ubiquinol-cytochrome c reductase (QCR) and cytochrome c oxidase (CcO). They are 
commonly referred to as Complex I, II, III, and N, respectively. Figure 1 shows electron 
and proton transfer paths in the mitochondrial respiratory chain. Succinate and NADH, 
which mainly are derived from the citric acid cycle, are oxidized to fumarate and NAD+ by 
donating electrons to ubiquinone by SQR and NQR, respectively. The electrons on 
reduced ubiquinone (ubiquinol) are then transferred to cytochrome c by QCR Reduced 
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Figure 1. Electron and Proton Transfer Paths in The Mitochondrial Respiratory Chain. 
( Modified from reference ( 48)) 
2 
+ 
cytochrome c is finally oxidized by donating the electrons to molecular oxygen by CcO 
producing water. Electrons transferred through NQR, QCR, and CcO, are accompanied 
with translocation of protons across the mitochondrial inner membrane to generate a 
proton gradient for ATP synthesis (1, 2). 
3 
In recent years studies of mitochondrial electron transfer have focused on 
ubiquinone (Q). Q is a lipophilic molecule and abundant in the inner mitochondrial 
membrane. It has been considered as a mobile molecule shuttling electrons between SQR 
and QCR and between NQR and QCR Recently, this free status ofQ (Q-pool) (3, 4) has 
been challenged by an idea that Q has to be bound to protein in order to exert its electron 
transfer activity ( 4-6). Although evidence supporting these two ideas is accumulating, it is 
possible that both free Q and protein-bound Q are involved in the electron transfer chain. 
If the Q molecule which participates in electron transfer is strongly bound (high affinity) to 
its specific binding site, but is in redox equih'brium with free Q, then the ideas of Q-pool 
and Q-binding :function are complementary. 
Ahhough the electron transfer catalyzed by SQR does not generate proton 
gradient for ATP synthesis, study of SQR has been vigorous because of its unique position 
in cell metablism and its catalysis of a Q-mediated electron transfer reaction. SQR serves 
as an electron entrance for succinate, which is produced by the citric acid cycle enzyme, 
into the respiratory chain for sequential electron transfer to produce ATP. A regulatory 
:function of this enzyme in energy metabolism is also likely. Furthermore, SQR has a 
relatively simpler subunit structure than NQR and QCR, making it an ideal system for 
studying Q-mediated mitochondrial electron transfer reactions. 
4 
Bovine heart mitochondrial SQR was first isolated by Ziegler and Doeg (7). 
However, that isolation procedure was poorly designed; the yield was low with variable 
purity. A simple and reproducible procedure was introduced in 1982 by our group (8). 
This method involves treatment of succinate-cytochrome c reductase with Triton X-100 to 
dissociate SQR from QCR followed by calcium phosphate column chromatography at 
different pH's. Purified SQR contains five protein subunits with apparent molecular 
weights of 70, 28, 14, 11, and 9 kDa, estimated by high resolution SDS-PAGE (9). The 
complex has six prosthetic groups: FAD, three iron-sulfur clusters ([2Fe-2S], [3Fe-4S], 
and [4Fe-4S] clusters), cytochrome hs6oheme, and Q (see Table I). The chemical 
structures of these prosthetic groups are shown in Figure 2. 
SQR can be resolved into two reconstitutively active parts: a soluble succinate 
dehydrogenase (SDH) and a membrane-anchoring protein :fraction. SDH has been 
purified and characterized in several laboratories (10, 11, 15, 16). Purified SDH possesses 
two types of enzymatic activities: redox dye activity and reconstitutive activity. The 
redox dye activity of SDH is its ability to transfer electrons from succinate to artificial 
electron acceptors, such as phenazine methosulfate and ferricyanide. The reconstitutive 
activity is its ability to reconstitute with QPs to form SQR The succinate-low Km 
ferricyanide activity of SDH correlates to its reconstitutive activity. Purified SDH contains 
two protein subunits with apparent molecular masses of70 and 28 kDa (16), 
corresponding to the two larger subunits in SQR The 70-kDa subunit contains a FAD 
and is called Fp; the 28 kDa subunit houses all three iron-sulfur clusters found in SQR and 
is named Ip. The amino acid sequences of Fp and IP subunits of SDH are available 
TABLE I 
THE SUBUNIT COMPOSffiON OF BOVINE HEART SUCCINATE-UBIQUINONE 
REDUCTASE AND ITS NHi-TERMINAL AMINO ACID SEQUENCE 
Molecular 
Mass (kDa) 
Name 
70 Flavin protein (Fp) 
27 Iron sulfur protein (Ip) 
Prosthetic group 
(content in SQR) 
His-FAD 
(5.8nmol/mg) 
2Fe-2S 
3Fe-4S 
4Fe-4S 
( 48 ngatom/mg) 
14 Q-bmdmg protein (QPsl) ) Heme 
(l.2nmol/mg) 
11 Q-binding protein (QPs2) 
9 Q-binding protein (QPs3) Quin one 
(2nmol/mg) 
Midpoint NH,.-terminal Ref. 
potential (mV) Amino Acid 
-79 SAKVSDAISA- 9 
8 
0 A([fAA- 10 
+60 
-260 
-180 LGTT AKEEMER- 11,12 
unclear 
+84 SDSKAASL- 12 
5 
8-a-N(3)-histidyl FAD 
I 
CH2 
I 
CH2 
I -
coo 
Ferroprotoporphyrin IX 
2Fe-2S 
3Fe-4S 
Iron-suJfur Clusters 
::*~;c~ Ip,],: 
CH3 
Ubiquinone 
Figure 2. Structures of the Prosthetic Groups in Succinate-Q Reductase. 
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through peptide (17) and nucleotide sequencing (18). Comparison of the available amino 
acid sequences of Fp and Ip subunits of SDH from all sources reveals a substantial degree 
of similarity (10, 11). 
7 
FAD is covalently linked to the Fp subunit in SQR via a 8cx-N(3)-histidyl linkage 
(Fig. 2) (19, 20) and its midpoint potential is determined to be -79 mV which is higher 
than that of free FAD (-219 mV) (10, 11). PosSI'blythe covalent linkage ofFADto 
protein raises the redox potential of FAD, allowing it to be reduced by succinate ( 11 ). 
Mutagenesis studies of E. coli fumarate reductase proved that succinate oxidation by FAD 
is only posSI'ble when FAD is covalently bound to protein (21 ). The FAD is also 
functionally, and probably, structurally located close to the substrate (succinate) binding 
site. A conserved tripeptide (His-Pro-Tor) in addition to conserved Arg, His, and Cys 
residues in the Fp was tentatively assigned to the active site by chemical modification and 
mutagenesis studies ofE. coli fumarate reductase andB. subtilis SQR(lO, 11). The 
histidine of this tripeptide is believed to play an important role in the protein 
donor/acceptor function by assisting the deprotonation of succinate (22 ). 
The three iron sulfur clusters in the Ip subunit of SDH, irrespective of their origin, 
are named: S-1, a [2Fe-2S]2+ cluster; S-2, a [ 4Fe-4S]2+ cluster, and S-3, a [3Fe-4S]2+ 
cluster (Fig. 2). All three clusters are ligated by cysteine residues of the protein (10, 11) 
and these cysteines of Ip are conserved in all species. The midpoint potentials of these 
three iron-su:fur clusters in reconstitutively active SDH and SQR are determined as: S-1, 0 
mV; S-2, -260 mV; and S-3, 60 mV (11, 23). Since S-2 center has extremely low 
potential and is not reducible by succinate, some reports have ruled out direct participation 
of this iron-sulfur cluster in catalysis of SQR (10, 23). However, there is still a possibility 
for center S-2 being involved in SQR catalysis if the determined S-2 center potential is 
artificially low due to anticooperative interaction among the redox carriers in the sample 
( 11 ). The reconstitution activity of SDH is directly proportional to the amount of S-3 
center (24). 
8 
The reconstitutively active, membrane-anchoring protein :fraction has been isolated 
and characterized in several laboratories ( 12-14 ). It is named as CII-3 and -4 ( 12 ), 
cytochrome b560 (13), and QPs (14). The term, QPs (Quinone-binding Protein in SQR), 
will be used for the membrane-anchoring protein :fraction throughout this thesis because it 
is named by our group. All these preparations show two protein bands in the SDS-PAGE 
system ofWeber and Osborn (25). However, the two-subunit QPs is :further resolved into 
three protein subunits (26) by the high resolution SDS-PAGE system of Schagger et al. 
(9). The apparent molecular masses of these three subunits are 14, 11, and 9 k:Da, 
corresponding to the three smaller subunits of SQR. They are named QPsl, QPs2, and 
QPs3, respectively. 
The function of QPs is to provide membrane docking for SDH and the Q-binding 
site for SQR. Soluble SDH can catalyze electron transfer from succinate to redox dyes, 
but it cannot catalyze the 2-thenoyltritluoroacetone (TTFA)-sensitive electron transfer 
from succinate to Q. Addition of QPs to soluble SDH converts SDH to the membrane-
bound, TTF A-sensitive SQR with detectable ubisemiquinone radical formation, indicating 
that QPs provides membrane docking for SDH ( 12-14) and the Q-binding site for the 
complex (27, 28). It is not clear, at present, whether one, two, or three QPs protein 
subunits are required for membrane docking and the Q-binding functions of QPs, because 
attempts to dissociate QPs into their individual subunits have, so far, been unsuccessful. 
9 
Isolated QPs contains 25 nmoles of cytochrome bs6o per mg protein (29). Since 
cytochrome bs6o in SQR is sub-stoichiometric to FAD and is not reducible by succinate, 
the direct participation of cytochrome bs60 heme in catalytic function of SQR is ruled out. 
However, a close physical association of cytochrome bs60 with SDH is evidenced by the 
following observations (29): (A) the dithionite reduced form of cytochrome bs6o in 
isolated QPs has a symmetrical a-absorption peak, which upon reconstitution with SDH 
becomes slightly broadened and shows a shoulder at around 553 nm, identical to that of 
cytochrome bs6o in SQR (B) Dithionite reduced cytochrome bs6o in QPs is reactive to 
carbon monoxide while cytochrome bs6o in SQR is not reactive to carbon monoxide. 
Upon addition of SDH to QPs, the QPs becomes insensitive to carbon monoxide 
treatment. (C) The redox potential ofcytochrome bs6o in QPs is -144 mV, which is 
higher than that of cytochrome bs60 in SQR(-185 mV). Upon addition ofSDH, the 
redox potential of about 46% of the cytochrome bs6o in QPs becomes identical to that of 
cytochrome bs60 in SQR (D) Cytochrome bs6o in QPs shows two epr signals, g=3.07 
and g=2.92, whereas cytochrome bs6o in SQR exhibits only one epr signal at g=3.46. 
When QPs is reconstituted with SDH to form SQR, the g=3.46 epr signal reappears at the 
expense of the g=3.07 signal. 
In addition to the structural role of cytochrome bs6o in SQR, this cytochrome may, 
also, serve as a low potential electron entrance for :fumarate reduction (29), under special 
conditions. Under anaerobic conditions dithionite or NADH reduced cytochrome bs6o in 
SQR or QPs in the presence of SDH is fully oxidized by :fumarate, suggesting that 
cytochrome bs6o serves as the electron entrance for fumarate reduction (29). 
10 
The ligand for the cytochrome bs6o heme in SQR has been found as bis-histidine 
(30, 31 ). At present, it is not known whether both histidines come from QPsl, or one of 
them is in QPs2 or QPs3, even though QPsl is believed to be cytochrome bs6o in 
mitochondrial SQR The latter possibility will be ruled out if a cytochrome bs60 heme-
containing QPsl is obtained. 
Isolated SQR contains 2 nmoles of tightly bound Q per mg protein. The 
preparation is 40-50% deficient in Q content. The Q deficiency is determined by the 
extent of activity increase in Q-stim:ulated DCPIP reduction by succinate in the presence 
of excess Q in the assay mixture. The midpoint potentials of the two half reactions ( Q/Q· 
and Q·/QH2) ofQ in SQR were estimated to be 40 and 128 mV, respectively (28). The 
existence of Q-binding protein in SQR was proven by the detection of a TTF A-sensitive 
ubisemiquinone radical (28). Unlike the ubisemiquinone radical detected in QCR, the 
ubisemiquinone radicals detected in SQR do not show power saturation (28). The 
ubisemiquinone radical formation requires the presence of QPs, indicating that QPs 
provides a Q-binding site in this complex. Identification of QPs subunits responsible for 
Q-binding and location of the Q-binding domain are part of this thesis project. 
Study of Q:protein interaction in SQR with various Q-derivatives has generated 
vast information on the structural specificity of the Q-binding site in the complex. SQR 
requires Q with a five carbon alkyl side chain to exert maximum activity, while QCR needs 
Q with a 10 carbon chain length for maximum activity, indicating that the Q-binding sites 
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in these two complexes are different (32). The methoxy group at the 2- and 3- positions 
of the benzoquinone ring of the Q molecule is more important than the methyl group at 
the 5-position when Q is used as electron acceptor for SQR Replacing the 5-methyl 
group with hydrogen causes a slight increase in activity (33). However, replacing one or 
both of2- and 3-methoxy groups with a methyl completely abolishes electron-acceptor 
activity (33). By using [3H]azi.do-Q derivatives to study Q:protein interaction in QCR, the 
Q-binding proteins in this complex have been identified. We intend to use azido-Q 
derivative to identify Q-binding protein in SQR 
Although the electron transfer path in SQR are not yet fully understood, the dual 
pathway model (Fig. 3) (34), proposed by Cammack, has been popular. This model 
hypothesizes reduction of Q at two different sites. At one site, the two low potential 
redox components ofSQR, center S-2 (-260 mV) and cytochrome h560, (-180 mV) are 
needed to reduce Q to QH· and mediate electron transfer between the low potential 
FAD/FADH· (-127 mV) and Q/QH· (40 mV) couples. At another site, centers S-1 (0 
mV) and S-3 (60 mV) are involved to reduce QH· to QH2 and mediate electron transfer 
between high potential FADH·/FADH2 (31 mV) and QH•/QH2 (128 mV) couples. 
Electron transfer from succinate to FAD by a two-electron step is a 
thermodynamically unfavorable reaction, even if FAD is indeed located close to the active 
site, because the redox potential for the succinate/fumarate couple is +30 mV and for 
FAD/FADH2 couple -79 mV. How can this thermodynamatically unfavorable electron 
transfer reaction take place ? There are indications that the relaxation energy associated 
with a conformational change may assist this electron transfer step. SQR was reported to 
+30mV -79mV -260mV -180mV +40mV 
-127mV +84mV 
. : . -{• S-2redx Cytbox 
succinatexFAD 
S-2 ox Cyt bred 
FADH" t S-lredx S-3ox fiunarate FADH2 
S-1 ox S-3 red 
Q 
-31mV 
OmV 60mV +128mV 
Figure 3. Dual Pathway Model for Electron Transfer through Succinate-Q Reductase. 
(Modified from reference (34)) 
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have different substrate affinities for oxidized and reduced states, indicating that a 
conformational change is associated with the change in redox state of enzyme. The 
dissociation constant, Kd, for succinate is 16-fold higher for reduced SQR compared to 
oxidized enzyme. The Kd for fumarate is 4-fold higher for the the oxidized enzyme than 
for the reduced one (10). 
FAD serves as a converter from n=2 to n= 1 during oxidation of succinate. It 
accepts electrons from succinate in a two-electron step and donates electrons to iron-
sulfur clusters in two sequential one-electron steps. Oxidation ofFADH2 by iron-sulfur 
clusters with two one-electron transfer reactions is supported by the detection of very 
stable flavosemiquinone radicals in SQR (10). FADH2 donates its first electron to high 
13 
potential iron-sulfur center S-1 to generate F ADH· which then subsequently donates 
another electron to low potential iron-sufur center S-2 to generate oxidized FAD. Thus, 
dual electron transfer paths are generated for subsequent electron transfers from S-1 to S-
3 and from S-2 to cytochrome h560 to reduce Q to QH· and QH· to QH2, respectively. 
The observation ofQ· Q· interaction in SQR by EPR study (35) supports the 
presence of two Q-binding sites in SQR Moreover, mutagenesis study of E. coli quinol-
fumarate reductase identified several amino acids essential for enzymatic activity in the 
membrane anchor proteins (36). By mapping these residues on the proposed secondary 
structure, two quinone-binding sites were revealed, like the well characterized two 
quinone binding sites of the photosynthetic reaction center (36, 37). These results further 
support the speculation of the existence of two Q-binding sites in SQR 
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Figure 4 shows the proposed topological arrangement of subunits and redox 
centers of SQR in the mitochondrial inner membrane. This arrangment is consistent with 
data obtained from biochemical and biophysical studies of SQR and accomodates the 
proposed dual-pathway model of electron flow in the complex. The Fp subunit of SDH is 
located at the matrix surface of the mitochondrial inner membrane, which can receive the 
substrate, succinate, from and send the :fumarate back to the citric acid cycle (38-41). The 
Ip subunit of SDH serves as the link between QPs and the Fp subunit (39, 40). QPs 
subunits are mostly buried in the membrane. 
Interaction of SDH with QPs is known to be through hydrophobic and ionic 
reactions ( 6) as SDH can be detached from QPs by either chaotropic reagents or alkaline 
pH treatment. The ionic interaction is further supported by chemical modification studies 
ofQPs and SDH revealing that two carboxyl groups and a histidine residue in QPs (42, 
43) and an amino group in SDH ( 44) are essential for this interaction. 
The S-3 iron-sulfur cluster is located in the hydrophobic region of the Ip subunit of 
SDH, and QPs is generally believed to bind in the vicinity of the S-3 center (27). The Ip 
subunit of SDH is possibly associated with the inner membrane via a short NHz-terminal 
membrane anchor from the observation that the NHz-terminus of Ip consists of a stretch of 
nine uncharged residues (45). EPR studies suggest that FAD is 12-18 A apart from S-1, 
and S-1 is 9-12 A from S-2 and 10-20 A from S-3 (10, 46). 
The interaction of QPs with the Ip subunit of SDH is probably through the NHz-
terminal portion ofQPsl, as the proposed secondary structure ofQPsl, based on the 
deduced amino acid sequence (26), shows three transmembrane helices with its NHz-
succinate fumarate 
JOH 
OH 
Matrix 
+ 
sA Q 
.. t ............... . I 
so A 
+-- QPs 
Intermembrane space 
Figure 4. Topological Arrangement of Subunits and Redox Centers in Succinate-Q 
Reductase (Modified from reference ( 10) ). 
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terminus on the matrix side. It is also possible that all three subunits of QPs are involved 
in interaction with the Ip subunit of SDH. At present, the topological arrangement of QPs 
subunits in the membrane is unknown. Study on this aspect is currently in progress in our 
laboratory. 
The two ubisemiquinone radicals in SQR are about 8 A apart as estimated by EPR 
spectral analysis. Their alignment is not face to face but edge to edge ( 4 7). The dipolar 
axis ( quinone-quinone direction) is approximately perpendicular to the membrane plane in 
a trans-membrane fashion as a rigidly bound quinone pair ( 4 7). By examining the power 
saturation characteristics of S-3 and coupled signal, at least one of the Q's was found to 
be proximal to S-3 (35). Also, it is suggested that cytochrome bs6o may be necessary for 
the binding and simultaneous stabilization of two semiquinones (27). 
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CHAPTER I 
THE AMINO ACID SEQUENCE OF QPsl 
Structure-function study of SQR requires knowledge of the amino acid sequences 
of all the subunits in this complex. The amino acid sequences of Fp and Ip subunits of 
SDH are available by sequencing peptide (1) and nucleotide sequences (2), respectively, 
but the amino acid sequences of QPs subunits are mostly lacking. Recently, a cDNA 
encoding QPsl has been obtained in our lab by immunologically screening the bovine heart 
cDNA library in 11,gtl 1 with antibody against QPsl (3). Since purified QPsl protein, 
obtained from preparative SDS-PAGE, had its NHrterminus blocked and was resistant to 
all proteolytic enzyme digestion, confirmation of this QPsl cDNA clone was achieved by 
mass spectrometry. The protonated molecular :fragments detected in the laser desorption 
time-of-flight mass spectrum ofQPsl correspond to the assigned :fragments in the deduced 
amino acid sequence ofQPsl. 
In the QPsl cDNA clone the coding sequence for mature QPsl was assigned to 
start with ATG, 27 bp downstream from the 5' end, with a total of 396 bp encoding 132 
amino acid residues. This assignment was based on the largest molecular mass :fragment in 
the mass spectrum of QPsl, 14320.2 (m/e ), and an apparent molecular weight of QPsl 
determined by SOS-PAGE of 14,000 daltons. This assigment leaves room for revision 
because the insolubility of QPsl may complicate QPsl molecular weight detemination by 
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mass spectrometry and hydrophobic protein molecular masses determined by SOS-PAGE 
are usually not very accurate. Of course, the most direct way to assign the start of the 
coding sequence for QPsl is to have a partial NH2-terminal amino acid sequence of QPsl 
available. 
The failure of our previous attempts in obtaining the partial NHrterminal amino 
acid sequence of QPsl was due to the blockage of the NHrterminus in isolated samples. 
It was reported ( 4) that proteins isolated by SOS-PAGE often have their NH2-terminus 
blocked resulting from the interaction of the amino group with unreacted acrylamide 
solution in gels after polymerization. This kind ofNHrterminus blockage of the protein 
can be prevented by using a residual acrylamide-free SOS-PAGE gel. This report 
motivated us to re-investigate the nature ofNHrterminus blockage in isolated QPsl and 
to obtain its partial NH2-terminal amino acid sequence. Obtaining the complete nucleotide 
and amino acid sequences ofQPsl are essential for structure-function study of this 
protein, such as localization of Q-binding domain and the molecular genetic study of 
QPsl. 
The uncertainty of the NHrterminus status ofQPsl raised the possibility of the 
QPsl cONA clone obtained in our laboratory being an incomplete clone which lacks an 
NH2-terminal presequence. It is highly likely that nascent QPsl is synthesized with a 
presequence, like the membrane-anchoring proteins of yeast SQR, to direct it to the inner 
mitochondrial membrane. Although information on the presequence is not important for 
structure-function studies of QPsl, it will help us understand the processing of QPsl in the 
cell. 
In this charpter I report isolation of a NHrteminus unblocked QPsl by SDS-
PAGE and the partial NHrterminal amino acid sequence ofQPsl. I also present a 
revised amino acid sequence of QPs 1 deduced from a revised nucleotide sequence. The 
presence of a presequence for QPsl is confirmed by nucleotide sequencing of a longer 
QPsl cDNA clone. 
Experimental Procedures 
Materials 
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DNase I (Type N), RNase A, ampicillin, agarose, sodium thioglycolate, 3-
[cyclohexylamino]-1-propanesulfonic acid (CAPS), bovine serum albumin, DCPIP, Triton 
X-100, sodium dodecylsulfate (SDS), N-[2-hydroxy-1,1-bis (hydroxymethyl) ethyl]glycine 
(Tricine), and sodium cholate were obtained from Sigma. Restriction endonucleases, T4 
DNA ligase, were purchased from either Promega Corporation or Bethesda Research 
Laboratories, Inc. Po]yvinylidene difluoride (PVDF) membranes were from Millipore. 
Other chemicals were obtained commercially in the highest purity available. 
Bacterial Strains and Plasmids 
E.coli JM109[recA1, endoAl, gyrA96, thr, hsdR17, supE44, re/Al A(lac, 
pro)F'traD36proAB laclq, lacZ M15] was used as host for pGEM-3Zf{+) (Promega). 
E. coli strains were grown in LB medium ( 5). When necessary, ampicillin ( 100 µg/ml) 
was added. 
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DNA Manipulation and DNA Sequencing 
Restriction enzyme digestion, large-scale isolation and minipreparation of plasmid 
DNA, isolation and purification of Lamda phage DNA were performed according to 
reported methods (5). The sequencing primers were synthesized and DNA sequencing 
was performed by the Recombinant DNA/Protein Resource Facility at Oklahoma State 
University. 
Enzyme Preparations and Assays 
Bovine heart SQR was prepared from SCR by the method previously reported ( 6). 
SQR containing fractions obtained from the second calcium phosphate-cellulose column 
were concentrated by 43% ammonium sulfate saturation and centrifugation at 48,000 x g 
for 20 min. The precipitate obtained was dissolved in 50 mM potassium/sodium 
phosphate, pH 7.8, containing 0.2% sodium cholate and 10% glycerol. 
SQR was assayed for its ability to catalyze Q reduction or Q-stimulated DCPIP 
reduction by succinate. The assays were performed at room temperature in a Cary 
spectrophotometer (model 219) or Shimadzu UV-2101PC. The reaction mixture used for 
the Q-stimulated DCPIP reduction assay contains 38 µmol ofDCPIP, 100 µmol of 
sodium/potassium phosphate buffer, pH 7.4, 20 µmol of succinate, 10 nmol ofEDTA, 25 
nmol ofQ0C10, and 0.01 % of Triton X-100 in the total volume of 1 ml. The reduction of 
DCPIP was followed by measuring the absorption decrease at 600 nm, using a millimolar 
extinction coefficient of21 mM-1cm-1. 
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Electroblotting of QPsl onto a PVDF Membrane 
SQR was treated with 1 % ,B-mercaptoethanol and 1 % SDS for 2 hrs at 37°C. 20-
µl aliquots of the digested samples were applied to wells of an SOS-PAGE gel which had 
been pre-electrophoresed overnight at 45 V with an anode buffer containing 0.2 M Tris-
Cl, pH 8.9, and 0.1 mM sodium thioglycolate and a cathode buffer containing 0.1 M Tris, 
0.1 M Tricine, 0.1 % SDS, and 0.1 mM sodium thioglycolate, pH 8.2. The proteins in 
SOS-PAGE gel were electroblotted to a PVDF membrane according to the procedure of 
LeGendre et al. (4) using CAPS transferring buffer (10 mM CAPS, 10% methanol, pH 
11) for 15 min. After the transfer was complete, the membrane was rinsed several times 
with HPLC-grade H20 before being stained with Coomassie blue R-250 (0.1 % in 50% 
methanol) for 2 min to visualize the proteins bound to the membrane. The blue band 
corresponding to QPsl was cut out and subjected to NH2-terminal sequence analysis. 
Amino Acid Sequence Determination 
Amino acid sequence analyses were done at the Molecular Biology Resource 
Facility, Saint Francis Hospital of Tulsa Medical Research Institute, University of 
Oklahoma Health Sciences Center, under the supervision of Dr. Ken Jackson. 
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Results and Discussion 
Revised Amino Acid and Nucelotide Sequences ofQPsl 
The partial NH2-terminal amino acid sequence ofQPs, obtained by 
microsequencing of QPsl protein blotted on a PVDF membrane, is: LGTTAKEEMER-. 
The success ofthis partial NH2-terminal amino acid sequence determination relies on the 
isolation of a QPsl protein having the NHrterminus unblocked during SDS-PAGE. The 
use of a pre-electrophoresed SDS-PAGE gel and inclusion ofO.l mM sodium 
thioglycolate in the running buffer prevented blockage of the NHrterminus during 
electrophoresis. The blockage of protein NHrtemini during SDS-PAGE is reported to be 
due to the covalent linkage ofNHrterminus with free acrylamide remaining in the gel (4). 
The residual ammonium persulfate and TEMED in the gel may catalyze this reaction. 
Therefore, pre-electrophresing the gel overnight, can remove all the remaining free 
acrylamide, ammonium persulfate, and TEMED. The inclusion of sodium thioglycolate in 
the running buffer of SDS-PAGE can keep the NH2-terminus reduced to prevent any 
possible reactions. 
From the partial NHrteminal amino acid sequence ofQPsl, it was obvious that 
our previously reported amino acid sequence for QPsl deduced from nucleotide 
sequencing is 8 amino acid residues short. The coding sequence for mature QPsl starts 
from 7 base pairs, instead of 31 base pairs, downstream from the 5' end of our isolated 
QPsl cDNA clone (3). Figure 5 shows the revised amino acid and nucleotide sequences 
ofQPsl. The molecular weight of mature QPsl is 15,149. Apparently the cDNA clone 
TTG AGA CAT GTT 
[ (M A A L L) L R H V 
GGC CGT CAC TGC CTC CGT GCC CAC CTT AGT CCT CAG CTC TGT ATC AGA AAT GCT GTT CCT 
GR H C LR AHL S P Q L C IR NA VP] 
1. 1.1. 
TTG GGA ACC ACA GCC AAA GAA GAG ATG GAG AGG TTC TGG AGT AAG AAC ACT ACT TTA AAC 
L G T T A K E E M E R F W S K N T T L N 
21. 31. 
CGT CCT TTG TCT CCC CAT ATC AGC ATC TAC GGC TGG TCT CTr CCC ATG GCG ATG TCC ATT 
RPLS PHIS I YGWSLPMAMS I 
41. 51. 
TGC CAC CGT GGC ACT GGT ATT GCC TTG AGT GCA GGA GTC TCT CTr TTT GGC TTG TCA GCC 
C H R G T G I A L S A G V S L F G L S A 
61. 71. 
CTC TTG GTC CCT GGG AGC TTT GAG TCT CAT TTG GAA TTT GTG AAG TCC CTG TGT TTG GGG 
L L V P G S F E S H L E F V K S L C L G 
81. 91. 
CCA GCA CTG ATC CAC ACA GCC AAA TTT GCA CTT GTC TTC CCT CTC ATG TAT CAC ACC TGG 
P A L I H T A K F A L V F P L M Y H T W 
1.01. 1.1.1. 
AAT GGG ATC CGA CAC TTG ATG TGG GAT CTA GGA AAA GGC CTG ACG ATT TCC CAG CTA CAC 
N G I R H L M W D L G K G L T I S Q L H 
1.21. 1.31. 
CAG TCT GGA GTG GCT GTC CTG GTT CTT ACT GTG TTG TCC TCT GTA GGG CTG GCA GCC ATG 
Q S G V A V L V L T V L S S V G L A A M 
TGA 
* 
AGAGCTGAAGTTCCCAGTGTCATCATCCTACAAATTATCACATTGACCTGTCTrCCTGTTTGTTACTCTTGTCTTTGGC 
CAGGGCAAAGTTATTCTGATTTGTTTAGACCCTrCTTTGCTrGCAGATCCCCTrGGAGCTCAGCAGTAGAGTACCTTAC 
AGAACCATAACGGTGGAAAAGGGTCCAGTTTTCTCCTTATTTATAAGGATGGAATGACTGCAAAAACTCCCTTTTCTrG 
CCCCCGCGTTGCAGCCTACTCTGGGCTTGGGAGCCTTCTTTCTCTCTCCATGTTAGGCCTrGATTTATGCTGAGGGTCA 
GCCTTTGGCTCCTTTTTCCTGAGACAGTGGAAACAATGCc;:AGCTCTGTGGCCTCTGCCGTGGGGACTGGGAGTGGGGAT 
CCGGGTGCCACTGCCTGTGGGTTGCTGGCTCAAAGGACAATTCTGTCCATTGGTCAGAGCCCAGGGTCTTTAGCGCCCA 
CATAGTGTGACTGAAAGGAGAGGGGCCCGAATTC 
Figure 5. Nucleotide Sequence of cDNA Encoding Bovine QPsl and Its Deduced Amino 
Acid Sequence. ([ ], leader sequence; underlined, NH2-terminus amino 
acid sequence determined by peptide sequencing; bold, added nucleotide 
and amino acid sequence in the longer cDNA clone; ( ), missing leader 
sequence of our clone; number, amino acid number of mature QPsl) 
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for QPsl isolated in our laboratory is a partial clone; it contains a complete sequence for 
mature QPsl, but lacks some amino acid residues of the leader peptide ofQPsl. In fact, 
the isolated QPsl clone contains only two codons for amino acid residues, Proline (P) and 
Valine (V), from the COOR-terminal end of the leader peptide. 
Presequence ofQPsl 
In order to study the presequence of QPsl, a complete cDNA clone for QPsl 
which encodes mature QPsl and presequence is required. A longer cDNA clone for QPsl 
was available in our laboratory making it a likely candidate containing the complete 
presequence ofQPsl. Therefore, the 5' end region of this cDNA insert was sequenced 
using a synthetic squencing primer, GCACGCGGAAGAAGGCACATGGCT, which 
matches with the position 981-1004 on the 11,gtll sequence. The clone is 1003 bp long. 
This longer QPsl cDNA clone does not have the methione start coding sequence (ATG) 
between the 5' end start of cDNA insert and the the NH2-terminus coding sequence of 
mature QPsl (shown in Fig. 5), indicating that this is also an incomplete cDNA clone for 
QPsl. Before proceeding to isolate a complete cDNA clone for QPsl from the cDNA 
library from other vendors, the presequence ofQPsl was reported from Dr. Capaldi's 
laboratory (7). There are five codons missing from the presequence obtained from our 
laboratory. 
Figure 6 compares the leader peptide of QPsl with those of SQR subunits from 
other eukaryotic species. The reported presequences of mitochondrial SQR subunits have 
a typical mitochondrial signal sequence. They contain a preponderance of basic (Arg and 
MLSLKKSALSKLTLLRNTRTf.TS~ALVR S.cerevisiae SDHl (10) 
MLNVLLRRICAl.CLV!KKGM S.cerevisiae SDH2 (11) 
MSAMMVKLGLNKSALLLKPSAFSRAAALSSSRRLLFNTARTNf.LSISPLK S.cerevisiae SDH3 (12) 
MMLPRSMKFMTGRRIFHTATV.AgAl_QSIAKKS S.cerevisiae SDH4 (13) 
MSGVRGLSRLLSARRLALAKAWPTVLQTGTRGf.HFIVDGNKRA Human liver Fp (14) 
- - - - -WRTC~QA~RG Human liver Ip (15) 
MSGVAAVSRLCARPALALTCTKWSAAWQTGTRSf.HFIVDGNKRS BovineheartFp(l6) 
{MAALL) LRHVGRHCLRAHL~PQLCIRNAVP Bovine heart QPsl (7, this 
chapter) 
Figure 6. Comparison of Amino Acid Sequence of Presequences From Different 
Eukaryotic Sources. (Reference numbers are indicated.) 
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Lys) and hydroxylated (Ser and Tur) residues and lack acidic residues (Glu and Asp) (8). 
It was suggested that mitochondrial membrane proteins, which contain the consensus 
sequence for cleavage by the matrix processing protease in their presequence, follow the 
two-step cleavage processing for mitochondrial targeting, and those which contain argine 
at the -2 upstream position follow a single-step cleavage processing. The consensus 
sequence is RX(F)XX(S), where R is arginine; Xis any amino acid; (F) is phenylalanine or 
other hydrophobic residues; and (S) is serine, threonine, or glycine. Since all four 
S.cerevisiae SQR peptides have the consensus sequences, these proteins may follow the 
two-step cleavage processing for mitochondrial targeting. Human liver mitochondrial Fp 
and Ip subunits of SDH, and bovine heart Fp have arginine at the -2 upstream position (9) 
and thus follow single-step cleavage. QPsl is more likely to follow the two-step cleavage 
because its presequence has a similar consensus sequence (RAHLS) and no arginine at the 
-2 upstream position. 
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CHAPTER II 
IDENTIFICATION OF THE UBIQUINONE-BINDING DOMAIN IN QPsl OF 
SUCCINATE-UBIQUINONE REDUCTASE 
33 
The goal of this thesis work is to understand the Q-mediated electron transfer 
reaction in mitochondrial SQR The active species of Q in electron transfer is proposed to 
be a protein-bound Q entity. The presence ofQ binding protein(s) in SQRis evidenced by 
the detection of a TTFA-sensitive ubisemiquinone radical in the complex and isolation of 
QPs which converts soluble SDH to a TTFA-sensitive succinate-Q reductase. The 
isolated QPs contains three protein subunits, QPsl, QP2, and QPs3, but it is not known 
which of the subunit(s) is responsible for the Q-binding function ofQPs. 
The availability of azido-Q derivatives in our laboratory allows us to study the 
Q:protein interaction and to identify the Q-binding protein in SQR by the photoaffinity 
labeling approach. Furthermore, if QPsl is identified as the Q-binding protein in the 
complex by the photoaffinity labeling technique, the availability of the amino acid 
sequence of QPsl ( Chapter I) will facilitate our identification of the Q binding domain in 
this subunit. 
The successfulness in isolation of the azido-Q linked peptide(s) from an azido-Q 
labeled protein relies on the susceptibility of isolated protein toward proteolytic enzyme 
digestion and separation of proteolytic peptides by HPLC. In this charpter I report the 
detailed conditions for photoaffinity labeling ofQ-binding protein(s) in SQR with the 
azido-Q derivative, and the detailed isolation procedure for the Q-binding domain in 
QPsl. 
Experimental Procedures 
Materials 
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Bovine serum albumin, DCPIP, Triton X-100, sodium cholate, TTFA, and 
potassium deoxycholate were obtained from Sigma. Molecular weight standards and urea 
were fromBioRad. n-Dodecyl-P-D-maltoside was fromAnatrace. Silica gel lB-F (2.5 x 
7. 5 cm) was from J. T. Baker. Jnsta-gel liquid scintillation cocktail was from Packard 
Instrument Co. Other chemicals were of the highest purity commercially available. 
The ubiquinone derivatives, 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone 
(QoC10), 3-azido-2-methoxy- and 3-azido-2-methoxy[3H]-5-methyl-6-decyl-1,4-
benzoquinones (3-azido-QoC10 and [3H]-3-azido-QoC1o), and 5-azido-2,3-dimethoxy- and 
5-azido-2,3-dimethoxy[3H]-6-decyl-1,4-benzoquinones ( 5-azido- Q0C10 and [3H]-5-azido-
QoC10) were synthesized according to methods reported previously (1). Calcium 
phosphate was prepared according to Jenner (2) and mixed at a 3:1 ratio with cellulose 
powder prior to use in column chromatography. 
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Synthesis of 3-Azido-2-Methyl-5-Methoxy-6-Geranyl- and 3-Azido-2-Methyl-5-Methoxy-
6-(3, 7-Dimethyl[ 3H]-Octyl)-1,4-Benzoquinones (Azido-0 and [3H]Azido-0) 
Scheme I summarizes the procedure for synthesis of azido-Q and [3H]azido-Q. 
Azido-Q and [3H]azido-Q was synthesized basically according to the method reported (1, 
3). Six-g of 4-methyl-3-nitroanisole (3) were mixed with lg of 10% Pd-C in 95ml of 
methanol. After addition of 5ml of methanol-HCl (2.47 M), the reaction was carried out 
for 40 min at 2 atm hydrogen pressure in a Parr shaker. The methanol solvent was 
evaporated in vacuo and the deep greenish oil was dissolved in 600ml of cold 0.5 M 
sulfuric acid. Then 250ml of a cold solution containing 27g sodium dichromate and 20 ml 
concentrated sulfuric acid was added slowly with stirring, the temperature being 
maintained at about 5°C. After stirring for 4 hours at room temperature the mixture was 
extracted with 200 ml CHCh four times. The combined deep brown extract was stirred 
with increasing amounts of florisil until the color of the solution became yellowish; florisil 
was removed by filtration. Upon removal ofCHCh, 0.5 g of yellow crystals of2-methyl-
5-methoxy-1,4-benzoquinone were obtained. 
Sixty-mg of2-methoxy-6-methyl-1,4-benzoquinone was dissolved in 20 ml of 
diethyl ether and shaken with 0.5 g sodium dithionite in 4 ml water until the solution 
became colorless. The mixture was extracted with diethyl ether. The reduced 
benzoquinone, obtained as colorless crystals upon removal of solvent, was dissolved in 4 
ml of dioxane, mixed with 80 ml of geraniol, and treated with 100 ml ofBF30(CiHs)2 over 
30 min with stirring. The mixture was stirred for 3 hours at room temperature, treated 
with 12 ml of water, and extracted with diethylether. The ether extract was dried over 
Scheme I. Synthesis of3-Azido-2-Methyl-5-Methoxy-6-Geranyl-1,4-Benzoquinone and 
3-Azido-2-Methyl-5-Methoxy-6-(3, 7-Dimethyl[3H]-Octyl)-1,4-
Benzoquinone. 
NOCH3 
CH3 I 
N02 Pd/C, H2 
Na2S204 
geraniol 
FeCh/H20 
Pd/C, MeOH + MeOH-HCl 
Ag;;_O, Na2S04 
H2* (H2*0 + Na) 
O OCH1 
I 
* * CH1 (CH2CH2CHCH2)tH 
0 CH1 
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Na2S04 and oxidized with 0.1 g of Ag20 for 1 hour with stirring. The solution was 
filtered and the filtrate was purified by silica-gel G plates developed with 
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hexane/ diethylether (3. 5: 1 ). 2-Methyl-5-methoxy-6-geranyl-1, 4-benzoquinone has an Ri, 
value of0.67. A by-product, 2-methoxy-5-methyl-6-geranyl-1,4-benzoquinone, with an 
.Ri,value of0.22, was also detected in the thin-layer plate. 2-Methyl-5-methoxy-6-
geranyl-1,4-benzoquinone was eluted with ether and upon removal of solvent, 9 mg of 
orange oil were obtained. IH-NMR (CDCh): 6.42 (q,1), 5.06 (t,2), 4.01 (s,3), 3.18 (d,2), 
2.02 (m, 7), 1.66 (t,9). UVrnax(95% ethanol): oxi., 263 nm; red., 288 nm. High resolution 
mass spectra, m/e, 288.1695. 
For the synthesis of 3-azido-2-methyl-5-methoxy-6-geranyl-1,4-benzoquinone ( 1 ), 
25 mg of 2-methyl-5-methoxy-6-geranyl-1,4-benzoquinone was dissolved in 1ml of acetic 
acid (90%), and incubated at 75 °C with constant stirring. The subsequent operations 
were performed in the dark. Three additions of sodium azide solution ( 17 mg sodium 
azide in 0.05 ml of water each) were made over a period of3 hours. After the additions of 
sodium azide, the mixture was stirred for 7 hours at 75 °C, concentrated, and purified by 
thin layer chromatography using the same solvent. The sample was eluted from the plate 
with ether. Upon removal of the ether, 0.5 mg of pure 3-azido-2-methyl-5-methoxy-6-
geranyl-1,4-benzoquinone was obtained. lH-NMR (CDCh): 1.66 (t,9), 1.98 (m, 7), 3.16 
(d,2), 3.98 (s,3), 5.04 (t,2). UV max (95% ethanol): oxi., 306 nm; red., 298 nm 
The 3-azido-2-methyl-5-methoxy-6-(3, 7-dimethyl[3H]-octyl)-1,4-benzoquinone ( 1) 
was obtained via hydrogenation of2-methyl-5-methoxy-6-geranyl-1,4-benzoquinone with 
tritiated hydrogen gas followed by azidolization with sodium azide. The tritiated 
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hydrogen gas was generated from tritiated water by addition of metallic sodium in one arm 
of the "H" shaped apparatus after evacuation. Metallic sodium was hooked by a movable 
wire through a silicone plug. The amount of tritiated water used was calculated to be 
enough to generate a pressure of3 atm of tritiated hydrogen in the apparatus. 2-Methyl-
5-methoxy-6-geranyl-1,4-benzoquinone and Pd/C were mixed and placed in the other arm 
of the "H'' shaped apparatus and the whole system was subjected to evacuation. During 
evacuation, the arm containing tritiated water was placed in a dry ice-acetone bath to 
decrease evaporation. After evacuation, the metallic sodium was slowly lowered into the 
water to generate the tritiated hydrogen gas. The hydrogenation was completed in 3 hrs 
at room temperature with vigorous shaking. Specific radioactivity for the 3-azido-2-
methyl-5-methoxy-6-(3, 7-dimethyl[3H]-octyl)-1,4-benzoquinone was 57,300 cpm/nmol, 
which was determined in a Beckman liquid scintillation counter. 
Enzyme Preparations and Assays 
Bovine heart SQR was prepared from SCR by the method previously reported ( 4) 
except that succinate was omitted from all buffers used in the purification procedure. 
SQR containing fractions obtained from the second calcium phosphate-cellulose column 
were concentrated by 43% ammonium sulfate saturation and centrifugation at 48,000 x g 
for 20 min. The precipitate obtained was dissolved in 50 mM potassiun/sodium 
phosphate, pH 7.8, containing 0.2 % sodium cholate and 10 % glycerol 
SQR activity was assayed for its ability to catalyze Q reduction or Q-stimulated 
DCPIP reduction by succinate. The assays were performed at room temperature in a Cary 
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spectrophotometer (model 219) or Shimadzu UV-2101PC. The reaction mixture used for 
the Q reduction assay contains 100 µmol of sodium/potassium phosphate buffer, pH 7.4, 
20 µmol ofsuccinate, lOnmol ofEDTA, 25 nmol ofQoC10 and 0.01 % ofn-dodecyl-P-
mahoside in the total volume of 1 ml The reduction of QoC10 was followed by measuring 
the absorption decrease at 275 nm, using a millimolar extinction coefficient of 12.25 mM' 
1cm·1. The reaction mixture used for the Q-stimulated DCPIP reduction assay contains 38 
µmol ofDCPIP, 100 µmol of sodium/potassium phosphate buffer, pH 7.4, 20 µmol of 
succinate, 10 nmol ofEDTA, 25 nmol ofQoC10, and 0.01 % of Triton X-100 in the total 
volume of 1 ml. The reduction ofDCPIP was followed by measuring the absorption 
decrease at 600nm, using a millimolar extinction coefficient of21 m.M'1cm·1. 
Isolation of[3H]Azido-O labeled OPsl 
A brief procedure from labeling of SQR with [3H]azido-Q to isolation of Q-binding 
peptide is summarized in scheme II. 10ml of succinate-Q reductase, 1.5 mg/ml, in 50 mM 
sodium/potassium phosphate buffer, pH 7.8, containing 10 % glycerol and 0.2 % sodium 
cholate were incubated with 125 µl of[3H]azido-Q (9.6 mM in 95 % ethanol) at O °C for 
10 min in the dark. The specific radioactivity of azido-Q used was 1.6 x 104 in 95 % 
ethanol and 6.6 x 103 cpm/nmol in 50 mM potassium/sodium phosphate buffer, pH 7.8, 
containing 10 % glycerol and 0.2 % sodium cholate in the presence ofSQR This mixture 
was transferred to an illumination apparatus made from two quartz glasses sandwiched by 
a Teflon ring. The apparatus was immersed in cold water in a Petri dish surrounded with 
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Scheme II. Isolation of[3H]-Azido-Q-Binding Peptide. 
succinate-free SQR [3H]azido-Q 
l shine long wavelength UV light for 7 min at a distance of 5 cm 
UV light 
cold water 
l 
, 
illuminated [3H]azido-Q-treated SQR 
l -Am.S04 precipitation - dialysis 
- organic solvent extraction 
- lyophilization 
( [3H] azido-Q-labeled SQR ) j -·apply to high resolution SDS-PAGE - cut out QPsl band 
- elute QPsl electrophoretically 
( [ 3H]azido-Q-labeled QPsl) j -reductive carboxymethylation - digestion by trypsin 
- apply to reverse phase HPLC 
( [ 3H]azido-Q-binding domain) 
41 
salted ice to maintain the temperature of the water at O °C. The sample was illuminated 
with long wavelength UV light for 7 min at a distance of 5 cm from the light source. 
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The illuminated [3H]azido-Q-treated SQR was precipitated by 43 % ammonium 
sulfate saturation and centrifuged at 48,000 x g for 20 min. The precipitate was dissolved 
in 10 mM Tris-Cl buffer, pH 7.8, and dialyzed against double distilled water overnight 
with one change of water. The free Q or the phospholipid bound Q was extracted from 
the protein by organic solvent (1). The dialyzed sample (0.8ml} was mixed with 2 ml of 
methanol and 1 ml chloroform, and incubated at room temperature for 30 min with 
occasional shaking. After incubation, 1 ml of H20 and 1 ml of chloroform were added and 
the mixture was kept at room temperature for another 10 min with occasional shaking. 
The chloroform layer was separated from the aqueous layer by centrifugation and 
discarded. The aqueous layer was extracted once more with 1ml chloroform and the 
chloroform layer was removed. The methanol in the aqueous layer was evaporated under 
a stream of nitrogen gas before the solution, which contained the photolyzed protein, was 
subjected to lyophilization. The lyophilized sample was suspended in 20 mM Tris-Cl, pH 
8.0 containing 1 % SDS. ,B-mercaptoethanol was added to a final concentration of 1 % 
and the solution was incubated at 37 °C for 2 h before it was subjected to preparative 
SDS-PAGE. The SDS-PAGE gel was prepared according to Schagger et al. (5) except 8 
M urea was used in the separating gel instead of 13 % glycerol. The SDS-,B-
mercaptoethanol treated sample was loaded onto a gel slab in two strips sandwiched with 
three reference wells ( one on each side and one at the center) loaded with the digested 
samples treated with fluorescamine. The electrophoresis was run at 15 V for 2 hand then 
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at 35 V for another 17 h with a Mini-protean II cell ofBio-Rad. The protein bands were 
visualized by fluorescence under UV. The SOS-PAGE pattern of the :tluorescamine-
treated sample was identical to that of the untreated sample as established by Coomassie 
Blue staining. The QPsl protein band was excised from the SDS-PAGE gel and the 
protein was eluted with an electroeluter from Bio-Rad. 
Reductive Carboxymethylation of Azido-0-Labeled OPsl 
The QPsl protein solution was subjected to reductive carboxymethylation by a 
modification of the method reported previously (6). The electrophoretically eluted QPsl 
protein solution was concentrated to a protein concentration of about 3 mg/ml by 
membrane filtration using Centricon-10 and precipitated with 50 % cold acetone (-20°C}. 
The protein precipitate was suspended in 1 ml of cold water and centrifuged at 
100,000 x g for 1 hr to remove the trace of acetone remaining in the protein. The 
precipitate thus obtained was homogenized in 0.1 M Tris, 6 M guanidine HCI, 1 mM 
EDTA, pH 8.3. Dithiothreitol was added to the suspension to a final concentration of2 
mM. The solution was made anaerobic by passing argon through it and then incubated at 
37 °C for 1 h. Iodoacetic acid, neutralized with NaOH, was added to give a final 
concentration of 5 mM. Argon was flushed over the surface of the reaction mixture, the 
vessel was sealed, and alkylation was allowed to go on in the dark at 37 °C for 1 h. 
Complete alkylation was achieved by an additional treatment with 1 mM dithiothreitol and 
incubation with 2 mM iodoacetate under the same conditions. The alkylated protein 
solution was treated with ,B-mercaptoethanol to a final concentration of 1 % and dialyzed 
against 50 mM ammonium bicarbonate, pH 8.5 overnight at 4 °C with one change of 
buffer. 
Tr,YPsin Digestion of the Carboxymethylated Azido-0-Labeled OPsl 
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The carboxymethylated QPsl protein was collected from the dialyzed sample by 
centrifugation at 100,000 x g for 30 min. The collected precipitates were suspended in 0.1 
M ammonium bicarbonate-0.1 mM CaCh to a final protein concentration of lmg/ml and 
digested with trypsin at 37 °C for 2 hr using a trypsin:QPsl ratio of 1:50 (w/w). After a 2 
hr incubation, a second addition of trypsin was made (1: 100) and the incubation continued 
at 37 °C for 22 h. 
Isolation ofUbiquinone-Binding Ptmtides 
One hundred-microliter aliquots of the trypsin-digested QPsl were separated by 
high performance liquid chromatography (HPLC) on a Synchropak RP-8 column (0.46 x 
25 cm) using a gradient formed from 0.1 % trifluoroacetic acid and 90 % acetonitrile 
containing 0.1 % trifluoroacetic acid with a flow rate of 1 ml/min. One-milliliter fractions 
were collected. The absorbance at 214 nm and the radioactivity of each fraction were 
measured. 
Amino Acid Sequence Determination 
Amino acid sequence analyses were done at the Molecular Biology Resource 
Facility, Saint Francis Hospital of Tulsa Medical Research Institute, University of 
Oklahoma Health Sciences Center, under the supervision of Dr. Ken Jackson. 
Results and Discussion 
Preparation of SQR 
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Succinate, the substrate for SDH, has been routinely included in the preparation of 
SQR to stabilize the enzyme complex. However, the succinate-containing SQR 
preparation is not suitable for studying Q:protein interactions using the azido-Q derivative 
because in the presence of succinate, the azido-Q derivative is slowly reduced by SQR to 
aminoquinol, thus losing its photoaffinity labeling ability. Although the rate of conversion 
of azido-Q to aminoquinol by SQR in the presence of succinate is very slow, the reaction 
is complete within 20 min at O °C in the dark when the molar ratio of azido-Q to SQR in 
the system is less than 50. The conversion of azido-Q to aminoquinol was evident from 
the change of absorption characteristics and of mobility on TLC. Upon reduction, a 
purple spot with the R;;,value of0.57 (aminoquinol) was observed with concurrent 
disappearance of a yellow spot with the R;;,value of0.90 (azido-Q), on a TLC plate 
developed with a hexane:ether (2.5 : 1) mixture. When a succinate-free SQR was 
incubated with 10-fold molar excess of azido-Q, no purple spot was observed on the TLC 
plate after 20 min incubation at O °C in the dark. 
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The succinate-free, SQR was prepared by replacing Tris-succinate buffer with 
Tris-Cl buffer during the separation of SQR from QCR in Triton X-100 treated succinate-
cytochrome c reductase. Succinate was omitted from the subsequent buffers used in 
calcium phosphate column chromatography. 
It has been shown that the interaction of azido-Q derivatives with the cytochrome 
b-cl complexes from various sources (1, 7, 8) requires prior removal of endogenous Q 
from the complex. The reason for this is that the binding affinity of azido-Q derivatives to 
the Q-binding proteins (sites) is weaker than that of endogenous Q10. The succinate-Q 
reductase, prepared according to the procedure descn"bed (4), is 40-50 % deficient in Q 
content.. The Q deficiency in SQR preparations is measured by the extent of activity 
increase ofQ-stimulated DCPIP reduction by succinate in the presence ofQoC10 (25 µM) 
in the assay mixture. Attempts to further remove Q from SQR preparations by prolonged 
washing of the 2nd calcium phosphate: cellulose column or by repeating the ammonium 
sulfate fractionation in the presence of0.5 % sodium cholate, were unsuccessful. 
Therefore, a partially Q-deficient, succinate-free SQR was used in this study. 
Properties of Azido-0 derivatives 
Three azido-Q derivatives, 3-azido-QoCrn, 5-azido-QoCrn, and azido-Q (Fig. 7), 
were synthesized and tested for their suitability for identifying Q-binding sites in succinate-
Q reductase. All these derivatives exhibit partial electron acceptor activity for succinate-Q 
reductase. The maximal activity was 35, 23, and 8 % (Fig. 8) for 5-azido- QoC10, 3-azido-
QoCio, and azido-Q, respectively, compared with QoC10. 
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3-azido-QoC10 
CH10*N1 
CH30 I I CH~ 10H 
0 
5-azido-QoCio 
azido-Q 
Figure 7. Structures of Azido-Quinone Derivatives. 
48 
6 
C) 
E 
- 5 C 
·-E 
-
G) 
- 4 as C 
(.) 
(.) 
::::, 3 en 
0 
E 
::l 2 
->-~ 
> 1 
·-
-
(.) 
<C 
0 
0 5 10 15 20 25 
Concentration, µM 
Figure 8. Titration of Succinate-Q Reductase Activity with Q Derivatives. 1 ml assay 
mixture conatins lOOµmol of sodium/potassium phosphate buffer, pH 7.4, 
20 µmol of succinate, 10 nmol ofEDTA, 0.01 % ofn-dodecyl-~ 
maltoside, and indicated amounts of Q0C10( O ), 5-azido-QoC10 (x), 3-
azi.do-Q0C10 ( ~ ), and azi.do-Q ( D ). The reaction was started with the 
addition of succinate-Q reductase. The reduction of Q derivatives was 
followed by the absorbtion decrease at 275 nm, 315 nm, 289 nm, and 304 
nm.for ofQoC10, 5-azi.do-QoC10, 3-azido-QoC10, and azido-Q, respectively. 
A millimolar extinction coefficient of 12.25 was used for the oxidized 
minus reduced· form of Q-derivatives. 
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In order to use these azido-Q derivatives to identify the Q-binding proteins and to 
facilitate the study of the Q:protein interaction, it is necessary to synthesize them in a 
radioactive form [3H]-3-azido-QoC10 and [3H]-5-azido-QoC10 were prepared by 
methylation of the hydroxyl group(s) on 3-H-2-hydroxy-5-methyl- and 5-H-2,3-
dihydroxy-6-decyl-1,4-benzoquinones, respectively, with C[3H]3J before being subjected 
to nucleophilic substitution with NaN3. And [3H]-azido-Q was obtained by hydrogenation 
of geranyl group on 3-H-2-methyl-5-hydroxy-6-geranyl-1,4-benzoquinones with tritium 
before azidolization. These [3H]azido-Q derivatives have the same electron acceptor 
activity for SQR as the unlabeled compounds (Table II). However, when SQR was 
incubated with 40 molar excess of these [3H]azido-Q derivatives for 10 min at O °C in the 
dark prior to illumination with a long wavelength UV light for 7 min, only the [3H]azido-Q 
treated sample showed inactivation and radioactivity uptake by protein (Table II), 
indicating that this [3H]azido-Q derivative is suitable for studying the Q:protein interaction 
in SQR The failure to detect 3-azido- QoC10 and 5-azido- QoC10 uptake by SQR during 
illumination is most likely due to intramolecular cyclization between the generated nitrene 
and its neighboring methoxy or methylene group on the Q molecule, during illumination. 
This [3H]azido-Q has been successfully used to identify the Q-binding site in cytochrome 
b-cl complexes from several sources (1, 7, 8). 
Effect of Azido-0 Concentration on SOR Activity After fflumination 
When SQR was incubated with various concentrations of [3H]azido-Q and 
illuminated, the activity decreased as the concentration of azido-Q increased. Maximum 
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TABLE II 
ELECTRON ACCEPTOR AND PHOTOAFFINITY LABELING ACTVITIES OF 
[3H]AZIDO-Q DERIVATIVES FOR SUCCINATE-Q REDUCTASE 
[ 3H]-Azido-Q derivatives 
3-N3-2-C[3H]30-5-CHr 
6-decyl-1,4-benzoquinone 
5-N3-2,3-di C[3H]30-
6-decyl-l, 4-benzoquinone 
3-N3-2-CH3-5-CH3 0-
6-(3, 7-di C[3H]3-octyl)-
1,4-benzoquinone 
Electron acceptor 
activity for SQRa 
SQR treated with 
[ 3H]Azido-Q derivatives h 
Activity 
-hv +hv 
Radioactivity uptake 
by protein upon 
illumination 
µmol succ./min/mg µmol succ./min/mg cpm/mg 
7.10 
1.58 7.10 7.08 0 
2.53 7.05 7.01 0 
0.62 7.08 4.21 5.73x104 
a 25 µM of indicated Q-derivatives were included in the assay mixture for succinate-Q 
reductase ( SQR). 
h 200-µl aliquots of succinate-Q reductase, 1.5 mg/ml, in 50 mM phosphate buffer, pH 7.8, 
containing 0.2% sodium cholate and 10% glycerol, were mixed with 5 µ1 of [3H]azido-Q 
derivatives, 13.2 mM in 95% ethanol. These [3H]-azido-Q-treated succinate-Q reductase 
preparations were incubated in the dark for 10 min prior to illumination. Aliquots were 
withdrawn from [3H]azido-Q treated samples, before and after illumination, for enzymatic 
and radioactivity uptake assays. The activity and radioactivity uptake were performed as 
described in "Experimental Procedures". The radioactivities for 3-Nr2-C[3H]30-6-decyl-
1,4-benzoquinone, 5-Nr2,3-di-C[3H] 30-5-CH3-6-decyl-1,4-benzoquinone, and 3-N3-2-
CH3-5-.CH30-6-(3,7-di C[3H] 3-octyl)-1,4-benzoquinone were 5.9 x 103, 1.3 x 102, and 
6.6 x 103cpmfnmol, respectively, in 50 mM phosphate buffer, pH 7.8, containing 0.2% 
sodium cholate and 10% glycerol in the presence of succinate-Q reductase. 
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inactivation of approximately 35 % was obtained when 40 mol of azido-Q/mol of FAD 
was used (Fig. 9). Inactivation was not due to inhibition ofSQR by photolyzed products 
of azido-Q because, when azido-Q was photolyzed in the absence of reductase and then 
added to SQR, no inhibition was observed. The maximum inactivation of 35%, which is 
in close agreement with the 40-50 % deficiency ofQ in the preparation, suggests that the 
affinity of endogenous Q for its binding site is much stronger than that of the azido-Q 
derivative. Since SQR activity is assayed in the presence of excess QoC10 (25 µM), the 
extent of inactivation of the azido-Q-treated SQR, after illumination, is a measure of the 
fraction ofQ-binding sites covalently linked to azido-Q. 
If azido-Q can occupy 35 % of the Q-binding sites in the reductase, one would 
expect to see a decrease in the activity of the azido-Q-treated sample before illumination, 
because this derivative has less than 10 % of the electron-transfer efficiency ofQoC10. The 
failure to observe a decrease in activity prior to illumination may be due to the fact that the 
concentration of QoC 10 in the assay mixture is several orders of magnitude higher than that 
of azido-Q. Thus Q0C10 can easily displace azido-Q from the binding sites, and the 
inferior electron-transfer activity of azido-Q is not expressed. After illumination, the 
covalently linked azido-Q cannot be displaced by QoC10 and inhibition occurs. 
Correlation Between Azido-0 Incorporation and Inactivation of SOR 
Figure 10 shows the effect of illumination time on the inactivation of, and azido-Q 
incorporation into, SQR When azido-Q-treated SQR was illuminated at 0°C for various 
lengths of time, activity decreased as illumination time was increased; maximum 
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Figure 9. Effect of Azido-Q Concentration on Succinate-Q Reductase Activity After 
illumination. Aliquots (0.2 ml) of succinate-Q reductase, 1 mg/ml (5.5 µM 
FAD), in 50 mM phosphate buffer, pH 7.8, containing 10% glycerol and 
0.2% sodium cholate were mixedwith 5 µl of an alcoholic solution of 
azido-Q derivative ( concentrations indicated), in the dark. After incubation 
at O °C for 10 min, the samples were illuminated for 7 min at O °C. 
Succinate-Q reductase activity was assayed before(e)and after ( o) 
illumination. 100% activity is succinate-Q reductase without treatment 
with azido-Q and without illumination. 
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Figure 10. Effect of illumination Time on Azido-Q Uptake and Inactivation of SQR. 
Aliquots (0.4 ml) of SQR, 1.5 mg/ml, in 50 mM phosphate buffer, pH 7.8, 
containing 10 % glycerol and 0.2 % sodium cholate were mixed with 10 µ1 
of ethanol (control) and 10 µ1 of [3H]azido-Q (13.5 mM in 95 % ethanol) in 
the dark. After incubating for 10 min at OoC in the dark, samples treated 
with [3H]azido-Q ( e ,0) and controls(•, .1) were divided into two equal 
portions: one was placed in the quartz cuvette and wrapped with aluminium 
foil (e, .1) and the other was placed in the quartz cuvette (o, .1) with 0.2-
cm light path. All samples were put in the same photolysis chamber and 
illuminated with long-wavelength UV light. The temperature in the 
photolysis chamber was maintained at O °C. At indicated time intervals, 2-µ1 
aliquots were withdrawn and assayed for SQR activity. To determine the 
radioactivity incorporation of [3H]azido-Q into the protein, aliquots (7-µ1) of 
[ 3H]azido-Q treated sample, with ( D) and without (1) illumination, were 
spotted on Whatman No.3 paper in the dark. When all samples were spotted 
and dried, the paper was developed with chloroform/methanol (2: 1, v/v). 
Proteins at their original spots were cut out and placed in scintillation vials 
containing 5 ml oflnsta-Gel. Radioactivity was determined with a Packard 
Model 1900 CA Tri-Carb liquid scintillation analyzer. 
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inactivation (35%) was reached in 7 min. The amount of azido-Q uptake by protein 
paralleled the extent of inactivation until the maximum was reached, indicating that 
inactivation results from binding of azido-Q to the ubiquinone binding site. Although 
illuminating for longer than 7 min caused no further decrease in activity, azido-Q uptake 
continued, but at a much slower rate, suggesting that this slower incorporation is due to 
nonspecific binding of azido-Q to proteins. The photoinactivation rate of succinate-Q 
reductase was affected by the protein, alcohol, and detergent concentrations in the system. 
Interaction with azido-Q derivative was most effective (i.e., showed the greatest degree of 
inactivation after illumination) when the reaction system contained SQR, 1-1.5 mg/ml, 
sodium cholate, 0.2%, and alcohol, <3%. 
Radioactivity Distribution of Azido-Q among Subunits of SQR 
Since the uptake of the azido-Q derivative by SQR during illumination correlated 
with the enzymatic inactivation, it is reasonable to assume that the azido-Q derivative was 
bound specifically to the Q-binding site(s). Thus, the distribution of the covalently bound 
azido-Q among the subunits of SQR after SDS-PAGE should indicate the specific Q-
binding polypeptide in this enzyme complex. Figure 11 shows the distribution of3H 
radioactivity among subunits of SQR. Prior to SDS-PAGE the reductase was extracted 
with organic solvent to remove most of the non-protein-bound azido-Q, such as free 
azido-Q or detergent-azido-Q or lipid-azido-Q adducts. The SQR contained 0.16 mol of 
azido-Q/ mol cytochrome bs6o- Radioactivity was found predominately in QPsl, 
suggesting that this protein provides the Q-binding site in this segment of the electron-
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Figure 11. Distribution of Radioactivity Among Subunits of Succinate-Q Reductase. 0.2 
ml of succinate-Q reductase, 1.5 mg/ml, in 50 mM phosphate buffer, pH 
7.8, containing 10% glycerol and 0.2% sodium cholate were mixed with 10 
µ1 of [3H]azido-Q (13.5 mM in 95% ethanol) in the dark. After incubation 
at O °C for 10 min, the sample was illuminated for 7 min at O °C. The 
illuminated sample was extracted with a mixture of chloroform/methanol 
(2:1) and lyophilized. The lyophilized sample was dissolved in 20 mM 
Tris-Cl buffer, pH 8.0, containing 1 % SOS and 1 % /J-mercaptoethanol and 
incubated at 37 °C for 2 hrs. The digested sample was treated with 
fluorescamine and applied to SOS-PAGE gel. The protein bands were 
visualized by fluorescence under UV and sliced. The portion containing no 
protein was also sliced to the same size as that of protein bands. The gel 
slices were smashed and mixed with 5 ml oflnsta-Gei and the radioactivity 
was determined. 
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transfer chain. Some radioactivity was found in QPs2 and QPs3; about 45% and 50% of 
that observed in QPsl. No radioactivity was found in the subunits of succinate 
dehydrogenase. Since the amount of radioactive labeling in QPsl was proportional to the 
extent of inactivation of the reductase, participation of QPsl in Q-binding is established. 
Although lesser amounts of radioactivity were found in QPs2 and QPs3, 
involvement of these two subunits in formation of the Q-binding site of SQR cannot be 
ruled out. The smaller azido-Q uptake by QPs2 and QPs3, compared to QPsl, may result 
from portions of the Q-binding sites being contributed by these two subunits, or from the 
preferable occupation of these two subunits by the endogenous Q present in the partially 
Q-deficient SQR used in this investigation. The role of QPs2 and QPs3 in Q-binding 
needs further investigation. The availability of a reconstitutively active, Q-depleted SQR, 
and of the amino acid sequences ofQPs2 and QPs3, would greatly help in the assessment 
of the involvement ofQPs2 and QPs3 in Q-binding of SQR. 
Preparation and Properties of Reductive Carboxymethylated, Azido-0-labeled OPsl 
In order to facilitate the identification of the Q-binding domain in QPsl through 
isolation and sequencing of an azido-Q-linked peptide, it is absolutely necessary to have 
isolated azido-Q-labeled QPsl free from contamination with unbound azido-Q and 
completely susceptible to proteolytic enzyme digestion. The [3H]azido-Q-labeled-QPsl 
was isolated from illuminated, [3H]azido-Q-treated SQR by a procedure involving 
ammonium sulfate :fractionation, dialysis, organic solvent extraction, lyophilization, 
preparative SDS-PAGE, electrophoretic elution, and cold acetone precipitation. Three 
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steps in the isolation procedure: organic solvent extraction, SDS-PAGE, and 50% cold 
acetone precipitation, are used to remove non-protein-bound azido-Q, some of which 
occurs as adducts with detergent or phospholipid. The electrophoretically eluted QPsl 
shows only one band in SDS-PAGE (see lane 1 of Fig. 12). The SDS, free azido-Q, and 
detergent-azido-Q adducts present in eluted QPsl preparation were removed by the 
acetone precipitation step. About 35% of the QPsl protein present in SQR was recovered 
in the final purification step, assuming that the molecular mass of succinate-Q reductase is 
136 kDa and that it contains 1 mol ofQPsl per mol ofreductase. This relatively low yield 
of QPsl is probably due to a very thin slicing of the QPsl band from SDS-PAGE gel to 
avoid contamination with QPs2 protein. 
The isolated azido-Q labeled QPsl was highly aggregated and resistant to 
proteolytic digestion. Inclusion of O .1 % SDS and 2 M urea in the digestion mixture did 
not increase proteolytic efficiency. Modification ofisolated a~do-Q-labeled QPsl protein 
by reductive carboxymethylation rendered the protein susceptible to trypsin and 
chymotrypsin digestion. The reductive carboxymethylation step was carried out in 50 mM 
Tris-Cl buffer, pH 8.3, containing 6 M guanidinium chloride. Guanidinium chloride (6 M) 
was found to be more effective than 50% N, N-dimethylformamide ( 6) in denaturation and 
in reduction of QPsl with dithiothreitol. The modified isolated QPsl contained 0.16 mol 
of azido-Q/ mol cytochrome bs6o. 
Isolation and Characterization ofUbiquinone-binding Peptides ofOPsl 
Figure 13 shows the distribution of radioactivity among the tryptic peptides of 
IP...,.. 
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Figure 12. SOS-PAGE of Purified [3H]Azido-Q-Labeled QPsl. Lane I, 
electrophoretically eluted QPsl; lane 2, succinate-Q reductase, and lane 3, 
molecular weight standards (phosphorylase b, 97400; bovine serum 
albumin, 66200; ovalbumin, 45000; carbonic anhydrase, 31000; soybean 
trypsin inhibitor, 21500; and lysozyme, 14400). 
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Figure 13. 3H Radioactivity Distribution on HPLC Chromatogram of Trypsin-Digested, 
[3H]Azido-Q-labeled QPsl Protein. The [3H]azido-Q-labeled QPsl (1 
mg/ml, 7.8 x 104 cpm/mg) was digested with trypsin, and 100-µl aliquots of 
digested solution were subjected to HPLC separation as descnoed under 
"Experimental Procedures." One hundred-µl aliquots were withdrawn 
from each tube for radioactivity determination. 
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QPsl separated by HPLC. When carboxym.ethylated [3H]azido-Q-labeled QPsl protein 
was digested with trypsin followed by HPLC separation using a Synchropak RP-8 column 
eluted with a gradient formed from 0.1 % trifluoroacetic acid and 90% acetonitrile in 0.1 % 
trifluoroacetic acid, the majority of the radioactivity was found in a fraction with retention 
time of 66.9 min (P-67). Although the presence of 0.1 % trifluoroacetic acid in the buffer 
system greatly increased the peptide resolution of QPsl on HPLC, these acid conditions 
cause a partial release of radioactivity during chromatography ( 6). Radioactivity recovery 
from the HPLC separation of trypsin-digested QPsl is about 62%. 
The partial NHrterminal amino acid sequence ofP-67 was determined to be 
GLTISQL-, which corresponds to amino acid residues 113-119 in the revised amino acid 
sequence of QPsl (Fig. 14 ). Although the isolated azido-Q linked peptide (P-67) was 
from a tryptic peptide containing amino acid residues 113-140 ofQPsl, the Q-binding 
domain, using the proposed structure ofQPsl (Fig. 14), is most likely located in the 
sequence connecting putative transmembrane helices 2 and 3. This region of the peptide is 
thought tp be extruded from the surface of the M side of the inner membrane. Threonine 
115 is probably the amino acid covalently linked to azido-Q upon illumination. This 
deduction is based on finding that the intensity of the threonine peak is much less than that 
of the other amino acid peaks during sequencing ofp-67. Neighboring amino acid 
residues, such as His 1°5, Trp108 and Asp 109, probably participate in the formation of Q-
binding site. More detailed information on Q-binding must await the availability of the 
three-dimensional structure of SQR. The information obtained from this study, however, 
can serve as a basis for future mutagenesis studies to identify the essential amino acid 
residues involved in Q-binding. 
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Fig. 14. Proposed Structure ofQPsl. The amino acid sequence ofQPsl was revised by 
the addition of 8 amino acid residues, LGTTAKEE, to the NHi-terminal end of 
our previously reported sequence (3). Bold line indicates the tryptic peptide 
isolated from P-67. 
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CHAPTER ID 
EXPRESSION OF QPsl PROTEIN OF SUCCINATE-UBIQUINONE REDUCTASE 
The Q-binding domain in QPsl was identified by previous study to be in the 
sequence connecting transmembrane helices 2 and 3. To better understand the molecular 
structure of the Q-binding site requires knowledge of amino acid residues involved in Q-
binding by this putative Q-binding domain. This can be achieved by an approach using 
expressed mutated QPsl protein to reconstitute, in vitro, a QPsl-lacking complex to form 
SQR In order to employ this in vitro reconstitution approach, the reconstitutively active 
QPsl-lacking SQR and an over-expressed, functionally active QPsl are needed. 
Recently, the small molecular weight Q-binding proteins, QPc (1) ofbovine heart 
mitochondrial QCR and subunit N (2) of the Rh.odobacter sphaeroides cytochrome bq 
complex, have been successfully expressed in Escherichia coli as glutathione S-transferase 
( GS T) fusion proteins using the pGEX expression system These reports, together with 
the availability ofQPsl cDNA in our laboratory, encouraged us to obtain functionally 
active QPsl by expressing QPsl in E. coli cells using the pGEX system The use of 
pGEX expression system allowed one-step purification of recombinant fusion protein by a 
glutathione agarose gel, thus greatly simplifying the purification procedure. 
In this chapter, I report the construction of a QPsl expression vector, 
pGEX/QPsl, development of optimal conditions for expression of QPsl, solubilization of 
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recombinant GST-QPsl protein from inclusion bodies, purification and characterization of 
recombinant GST-QPsl fusion protein obtained from cell extracts and from solubilized 
inclusion bodies, reconstitution of cytochrome bs6o from recombinant GST-QPsl fusion 
protein and heme, and isolation of the heme-reconstituted recombinant QPsl. 
Experimental Procedures 
Materials 
Restriction endonucleases, T4 DNA ligase, T4 DNA polymerase and T4 
polynucleotide kinase were obtained from either Promega Corporation or GIBCO BRL. 
DNase I (Type N), RNase A, IPTG, DMSO, gelatin, ampicillin, tetracycline, and X-gal 
were from Sigma. Nitrocellulose membrane was from MSI. Agarose, acrylamide, bis-
acrylamide, BCIP, NBT, and goat anti-rabbit IgG alkaline phosphatase were from Bio-
Rad. 
o-Aminolevulinic acid, ferrous sulfate, hemin chloride, sorbitol, betaine, glutathione 
(reduced form), glutathione-agarose beads, thrombin, and phenylmethylsulfonylfloride 
(PMSF) were from Sigma. LB agar, LB broth base, Select Peptone 140, and Select Yeast 
Extract were from GIBCO BRL. Oligonucleotides were synthesized by the Recombinant 
DNA/Protein Resource Facility at Oklahoma State University. Antibodies against QPsl, 
which ~ere generated in rabbits and purified by the method previously reported (3), were 
available in our laboratory. Other chemicals were obtained commercially in the highest 
purity available. 
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Bacterial Strains and Plasmids 
E.coli JM109[recA1, endoAl, gyrA96, thf, hsdR17, supE44, re/Al 11(/ac, 
pro)F'traD36,proAB, laclq, lacZ M15] was used as host for pGEM-3Zfl+) (Promega), 
pSelect (Promega), and pGEX-2T (Pharmacia) plasmids. E.coli DH5a[F 80d, 
lacZ!iM15 ~(lacZV A argF)Ul69, endAl, hsdRl 7(rk· mi/), deoR, thr, supE44, i.: 
,gyrA96, re/Al] was used as final host for pGEX-2TH/QPsl. E. coli strains were grown 
in LB medium ( 4 ). When necessary, ampicillin ( 100 µg/ml) or tetracycline ( 15 µg/ml) 
were added. 
DNA Manipulation and DNA Sequencing 
Restriction enzyme digestion, large-scale isolation and minipreparation of plasmid 
DNA, and isolation and purification of Lamda phage DNA were performed according to 
reported methods ( 4). Site-directed mutagenesis was performed using the Altered Site in 
vitro Mutagenesis system from Promega ( 5). The sequencing primers were synthesized 
and DNA sequencing was performed by the Recombinant DNA/Protein Resource Facility 
at Oklahoma State University. 
Isolation of Recombinant GST-OPsl Protein from Crude Soluble Extract 
Isolation of recombinant GST-QPsl fusion protein from crude soluble extract of 
E. coli DH5a/pGEX/QPsl cell culture was performed essentially according to the method 
described previously ( 1 ). Ten-milliliter of an overnight grown culture of E. coli 
DH5a/pGEX/QPsl was used to inoculate 100-:ml of bacterial growth medium (see Results 
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and Discussion) and incubated at 37 °C with vigorous shaking until the 00660nm reached 
0.9. The culture was cooled to about 27 °c and IPTG was added to a final concentration 
of lmM to induce synthesis of the GST-QPsl fusion protein. Cells were grown at 27 °c 
for 3 hours before being harvested by centrifugation at 8,000 x g for 15 min. Ten-gram of 
cell paste (which was obtained from 3 liter of the cell culture) were suspended in 20ml of 
20mM sodium/pottasium phosphate buffer, pH 7.3, containing 150mM NaCl (PBS). 
PMSF was added to the cells to a final concentration of lmM. The stock PMSF solution 
was 1 OOmM in absolute alcohol. The cells were broken by sonicating ( Heat Systems-
Ultrasonics Inc., model W-220F) for 10 sec three times with 1 minute intervals. Triton X-
100 was added to the broken cell suspension to a final concentration of 1 % (w/v). The 
suspension was then stirred for one hour at 0°C and centrifuged at 16,000 x g for 20 min. 
The supernatant was taken and mixed with an equal volume of glutathione-agarose gel 
equilibrated with PBS. The gel mixture was gently shaken for two hours at 0°C and 
centrifuged at 5,000 x g for 10 min to collect the beads. After washing five times with 
200ml of 50mM Tris-Cl buffer, pH 7.5, the GST-QPsl fusion protein was eluted from the 
column with 50mM Tris-HCI, pH 8.0, containing 5mM glutathione and 0.25M sucrose. 
Sample was dialyzed against 50 mM Tris-Cl, pH 8.0, containing 0.25Msucrose. The 
dialyzed sample was concentrated to lOmg/ml with Centricon-10, mixed with glycerol to a 
final concentration of 10%, and frozen at -80°C until use. Protein concentration was 
determined by the Lowry method ( 6) using bovine serum albumin as a standard. 
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Enzyme Preparations and Assays 
The cytochrome bs6o content was determined by pyridine hemochromogen spectra 
using the millimolar extinction coefficient of34.6 for reduced absorbance at 557 nm minus 
600 nm (7) or by difference spectra using the millimolar extinction coefficient of20.5 for 
reduced minus oxidized absorbance at 560 nm minus 575 nm (8). 
SDH was prepared and assayed according to the reported method (9). The 
reconstitutive activity of QPsl was assayed by its ability to give SQR activity upon mixing 
with SDH. Experimentally, GST-QPsl fusion protein samples were mixed with SDH and 
incubated for 10 min at 0°C. One-ml assay mixture contained lOOµmol of 
sodium/potassium phosphate buffer, pH 7.4, 50 nmol ofDCPIP, 20 µmol of succinate, 10 
nmol ofEDTA, 16 nmol ofQ2 and 0.1mg of Triton X-100. The reduction ofDCPIP was 
followed by an absorption decrease at 600 nm using a millimolar extinction coefficient of 
21 mMl-1cm-1. Absorption spectra and activity assays were performed at room 
temperature in a Shimadzu UV-2101PC spectrometer. 
SDS-PAGE and Western Blot Analysis 
Analytical SDS-PAGE was performed in a Bio-Rad Mini-Protein dual slab cell 
using the gel system ofLaemmli (10) with 10% or 12% of total monomer. The proteins 
on the SDS-PAGE gels were electrophoretically transferred to a nitrocellulose membrane. 
The membrane was blocked with 20 % Tris-Cl buffer, pH 7.4, 500 mM NaCl (TBS) 
containing 3 % gelatin for one hour at room temperature and washed with TBS and TBS 
containing 0.05 % Tween-20 (TTBS) for 5 min, respectively. The anti-QPsl antibodies 
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(15 µg/ml) in TTBS containing 1 % gelatine were 8then incubated with the membrane at 
room temperature overnight. After incubating with the primary antibodies, the blots were 
washed twice with TTBS for 5 min and then incubated with goat anti-rabbit lgG alkaline 
phosphatase conjugate (1: 2500 in TTBS containing 1 % gelatin) for one hour. After 
washing the membrane with TTBS and TBS for 5 min, respectively, the proteins were 
detected by showing alkaline phosphatase activity with BCIP and NBT as substrates. 
Prestained protein molecular weight standard was used to estimate the size of proteins on 
the gel and the membrane. The prestained protein molecular weight standard contained 
phosphorylase b (112,000), bovine serum albumin (84,000), ovalbumin (53,200), carbonic 
anhydrase (34,900), soybean trypsin inlnl>itor (28,700), and lysozyme (20,500). 
Results and Discussion 
Construction of the Expression Vector for OPsl 
Scheme ID summarizes the protocol used for construction of the QPsl expression 
vector, pGEX/QPsl. A new pGEX vector derivative, pGEX-2TH ( 1) which contained 
unique BamHI and Hindill sites ( constucted by Dr. U sui), was used in this investigation. 
An in-frame fusion of the QPsl gene with the glutathione-S-transferase gene in pGEX-
2TH plasmid was achieved by generating a BamHI-Hindill fragment encoding mature 
QPsl and subsequently ligating it into the BamHI and Hindill sites of the pGEX-2TH 
plasmid. 
In order to obtain a BamHI-Hindill cDNA fragment encoding mature QPsl, an 
internal BamHI site in the sequence needed to be deleted before a BamHI site 
Scheme ID. Construction of the QPsl ExprLssion Vector, pGEX/QPsl. 
Amp 5 
Amp' 
Sac I 
Sac I 
) 
,. 
Sacl 
1 . ...-,, Site-directed mutagenesis with: L 1. CTGGAATGGGATICGACACTIGAT (BamHI delete), 2. ATCAGAAATGCTGGATCCTIGGGAACCACA (BamHI create), 3. AAGAGCTGAAGCTICCCAGTGTCA (Hindlll create), 
4. Amp repair oligo 
Thrombin 
Leu Val Pro ArJ Gly Ser1 Pro Gly lie Gin Ala 
I CTG GTT CCG CGT GGA TC~GA A TT C.MJlQI. TGA A TT CCA TCG.ru!IC.rul\CTQ.ACG1 ~ Smal EcoRI Hind Ill ~ / 
11 
BamHI 
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(GGATCC) immediately upstream from the NH2-terminus coding sequence (TTG) and a 
HindIIJ. site (AAGCTT) 7-bp down stream from the stop codon (TGA) were created. 
This construction was achieved by using site-directed mutagenesis techniques. 
70 
A 1.7-Kbp Sacl-fragment from pGEM/QPsl was cloned into pSelect plasmid to 
generate pSelect/QPsl. The single stranded pSelect/QPsl was used as a template for 
mutagenesis. The mutant oligonucleotide, CTGGAA TGGGA TTCGACACTTGAT, 
along with an ampicillin repair oligonucleotide was included in the mutagenesis system to 
delete the interal BamH I site in QPsl sequence. Again, a Sacl fragment containing 
Bamfil-deleted QPsl sequence from pSelect amp+ /QPslLIBamHI was cloned into pSelect 
plasmid to generate pSelect amp- /QPslLIBamHI· The other two mutant oligonucleotides, 
ATCAGAAATGCTGGATCCTTGGGAACCACA (Bamm recognition), and 
AAGAGCTGAAGCTTCCCAGTGTCA (HindIIJ. recognition), along with an ampicillin 
repair oligonucleotide were included in the mutagenesis system The resulting plasmid, 
pSelect/QPslsBHS, was digested with Bamm and HindIIJ. to produce a 433-bp fragment 
containing the QPsl structural gene. This 433-bp Bamfil-HindIIJ. fragment was cloned 
into pGEX-2TH to generate pGEX/QPsl. pGEX/QPsl was transformed into E. coli 
JM109 or E.coli DH5a. Transformants producing the recombinant GST-QPsl fusion 
protein were identified by Western blot with antibodies against QPsl. 
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Effect of Induction Temperature, Media, and Time Length on Production of Recombinant 
OPsl in E. coli DH5a 
E.coli DH5a cells carrying pGEX/QPsl produced the GST-QPsl protein more 
efficiently than did E. coli JM109 cells containing this same plasmid. When overnight 
grown E. coli DH5a or JM109 cells carrying pGEX/QPsl was inoculated into growth 
medium, respectively, DH5a cells required 2.5 hrs and JM109 cells required 3.5 hrs to 
reach the midpoint of their logarithmic growth phase. Furthermore, the level of 
expression of the fusion protein from E. coli DH5a cells was higher than that from E. coli 
JM109 cells when estimated by SDS-PAGE of whole lysate. Thus, QPsl protein was 
expressed in E. coli DH5a cells. 
When E. coli DH5a cells containing pGEX/QPsl were treated with IPTG to 
induce systhesis of the GST-QPsl fusion protein at 37°C for 3 hours, about 8% of the 
total cellular protein produced was recombinant GST-QPsl fusion protein (see lane 1 of 
Fig. 15 (a)), indicating a high level of expression. The level of expression was estimated 
by comparing the color intensity of the 41-kDa protein band (GST-QPsl fusion protein), 
which reacted with antibdies against QPsl, with that of total cellular protein bands in 
SDS-PAGE. However, when the cells were broken by sonication, only 5% (0.4% of total 
cellular protein) of the fusion protein produced was recovered in the crude extract. 
Addition of Triton X-100 ( 1 % ) to the broken cell culture did not improve the recovery of 
the fusion protein in the crude extracts, indicating that the majority of recombinant fusion 
protein were synthesized in insoluble aggregates (inclusion bodies) when cells were grown 
at 37°C. 
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Figure 15. Total, Soluble and Inclusion Body Yield of GST-QPsl Fusion Protein 
Expressed on Various Growth Condition. 1 ml of cell culture 3 hrs after 
IPTG induction was removed and centrifuged, and the precipitate was 
suspended in 1 ml of PBS (for total yield). 250 µl of Triton X-100 treated 
sonicated cell suspension were removed and centrifuged, and the precipitate 
was suspended in 1 ml of PBS for inclusion body yield. For soluble yield, 
the supernatant after centrifugation was used. And 30µ1 of 1 % SOS and~-
mercaptoethanol treated sample was applied to SOS-PAGE. (A), Western 
blots of the SOS-PAGE: (a) LB broth medium, at 37°C, (b ), LB broth 
medium, at 27°C, (c), LB broth medium containing 440 mM sorbitol and 2.5 
mM betaine, at 27°C, (d) enriched medium, at 27°C, and (e) enriched 
medium containing 440 mM sorbitol and 2.5 mM betaine, at 27°C. Lanel is 
total yield, lane 2 is inclusion body yield, and lane 3 is soluble yield. (B ), 
Total yield ofGST-QPsl fusion protein was estimated from the gel of SOS-
PAGE by scanning it with densitometry. The yield from each fraction was 
obtained by comparing the color intensity of 41,000 Oa protein band (GST-
QPsl fusion protein), which reacted with antibodies against QPsl-15 kDa, 
with that of other cellular protein bands. 
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The insolubility of recombinant GST-QPsl fusion protein reduces its affinity for 
glutathionine agarose and thus limits the usefulness of the one-step purification scheme of 
the pGEX vector system Only when the recombinant protein is soluble ( or detergent 
soluble) and possesses a properly folded GST-active site, binding of the fusion protein to 
glutathione agarose is possible ( 11 ). There are two ways to achieve this goal: one is to 
change growth conditions to make cells produce active soluble recombinant protein; and 
the other is to develop methods to convert insoluble denatured recombinant GST-fusion 
protein into a soluble active form ( 1 ). 
Changes in cellular environments are known to increase the yield of active 
recombinant protein either by encouraging the cells to adopt the active conformation or by 
increasing the stability of recombinant protein. Variation of media, induction conditions, 
and length of induction are factors that affect the cellular environments. We 
systematically examined the effect of these factors on the yield of soluble recombinant 
GST-QPsl protein. Figure 15 compares the yield ofGST-QPsl fusion proteins produced 
in E. coli DH5a cells under five different growth conditions: (i) LB broth medium at 
37°C; (ii) LB broth medium at 27°C; (iii) LB broth medium containing 2.5 mM betaine 
and 440 mM sorbitol at 27°C; (iv) enriched medium (2% Select peptone 140, 0.2% 
Na2HP04, 0.1 % KH2P04, 0.8% NaCl, 1.5% Select yeast extract, and 0.2% glucose) at 
27°C; (v) enriched medium containing 2.5 mM betaine and 440 mM sorbitol at 27°C. 
Induction at 27°C improved the soluble yield over induction at 37°C, by 4-fold, 
but the total amount of recombinant GST-QPsl produced by the E. coli cuhure induced at 
270c was only 60% of that produced by the culture induced at 37°C. This result was 
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compatible with previous reports of increased soluble yield of recombinant polypeptide in 
E. coli using low induction temperature (1, 11-15). 
Although lowering the induction temperature increased the yield of soluble active 
GST-QPsl fusion protein, about 75% of the recombinant fusion protein still remained in 
inclusion bodies. To further increase the soluble yield, a method involving the use of 
osmotic stress to facilitate the uptake of the "compatible solute" glycyl betaine (1, 13) was 
adopted. When E. coli DH5a/pGEX-QPsl cells were grown at 27°C on LB medium 
containing 2.5 mM betaine and 440mM sorbitol, about 30% of the GST-QPsl produced 
(accounts for 8.3% of the total cellular protein) was in soluble form. Although the% 
distribution (30%} of produced GST-QPsl fusion protein in the soluble fraction for cells 
grown in the presence ofbetaine and sorbitol was only 5% higher than that for cells grown 
in the absence of these compounds (25%) at 27°C, the total yield ofGST-QPsl fusion 
protein increased from 5.3% to 8.3%. This suggests that inclusion ofbetaine and 
sorbitol in the growth medium not only promotes production of active soluble fusion 
protein, but also stimulates production of the fusion protein at low temperature. This 
result is similar to the report of increased the yield of active soluble GS T-QPc by including 
betaine and sorbitol in the growth medium ( 1 ). Although the resason for the increased 
yield of active soluble recombinant protein is unknown, it has been suggested that 
increasing internal concentrations of compatible osmolytes, such as betaine which are 
believed to be excluded from the immediate domains of proteins, causes a 
thermodynamically unfavorable "preferential hydration" and thus minimization of solvent-
protein contact and stabilization of protein structure (1, 13). 
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It has been reported that the recombinant protein can be induced in E. coli with the 
increased yield of the soluble form by using an enriched medium ( 14 ). When E. coli 
DH5a/pGEX-QPsl cells were grown at 27°C on enriched growth medium such as 
peptone-phosphate medium (2% Select peptone 140, 0.2% Na2HP04, 0.1 % KH2P04, 
0.8% Naci 1.5% Select yeast extract, and 0.2% glucose), about 9.4% of the total cellular 
protein were GST-QPsl fusion protein. About 15% of the fusion protein produced was in 
an active soluble form Although the cells grown on enriched medium produced more 
fusion protein than the cells grown on LB medium, the percent distribution of produced 
GST-QPsl in soluble fraction was lower than that for the cells grown on LB medium 
containing betaine and sorbitol. 
Since betaine and sorbitol increased the soluble yield of recombinant GST-QPsl 
for cells grown in LB medium, it was of interest to see whether these compounds could 
increase the soluble yield of recombinant fusion protein for cells grown in enriched 
medium When only 2. 5 mM betaine or 400 mM sorbitol was included into LB medium 
system, the soluble yield was increased to about 25% for each. However, addition of both 
2.5 mM betaine and 400 mM sorbitol to enriched medium increased the soluble yield to 
40% (Fig. 15 (e)). About 10.2 % of the total cellular protein was GST-QPsl fusion 
protein. Therefore, enriched medium containing both 2. 5 mM betaine and 400 mM 
sorbitol was the best condition for the production of the soluble recombinant GST-QPsl 
fusion protein. 
It should be mentioned that addition of Triton X-100 to the broken cell cultures 
obtained from all the above growth conditions did not improve the soluble yield of 
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recombinant protein, indicating that all the recombinant proteins in insoluble :fraction after 
sonication existed as an inclusion body aggregate instead of as membrane bound form 
However, Triton X-100 was included in our routine isolation procedure for recombinant 
GST-QPsl fusion protein to reduce cellular protein contamination during glutathione-
agarose gel affinity column chromatography (15). 
Production of recombinant GST-QPsl fusion protein was found to be dependent 
on IPTG-induction time (see Fig.16). The yield of the fusion protein increased, as the 
induction growth time was increased, to almost maximum yield which was obtained when 
cells were hearvested three hours after IPTG induction. When cells were grown for more 
than 3 hrs, the total yield did not increase much and the degradative products appeared 
more, suggesting that the recombinant protein was unstable and susceptible to protease 
digestion. In summary, the optimal condition for the production of soluble recombinant 
GST-QPsl fusion protein is as follows: induction of recombinant GST-QPsl fusion 
protein by IPTG at 27°C for three hours in E. coli DH5a cells containing pGEX/QPsl 
grown on enriched medium containing 2. 5 mM betaine and 440 mM sorbitol. 
Solubilization of Recombinant GST-OPsl Fusion Protein From Inclusion Body 
Precipitates 
Although lowering the induction temperature and introducing enriched medium 
containing 2. 5 mM betaine and 440 mM sorbitol increased the yield of soluble active 
GST-QPsl fusion protein, about 60 % of the recombinant fusion protein produced still 
remained in inclusion body complexes. The production of the sensitive protein, which is 
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Figure 16. Effect of Induction Time by IPTG on Expression ofGST-QPsl Fusion 
Protein on LB Medium Containing 2. 5 mM Betaine and 440 mM Sorbitol. 
77 
1 ml of cell culture was removed, centrifuged, and suspended in 500µ1 of 
PBS at 1, 2, 3, 4, and 5 hrs after inducing by IPTG. 30µ1 of suspension was 
subjected to SOS-PAGE. Total yield ofGST-QPsl fusion protein was 
estimated from the gel of SOS-PAGE by scanning it with densitometry. (A), 
SOS-PAGE of total cellular proteins before (lane 1), and 1 hr (lane 2), 2 hrs 
(lane 3), 3 hrs (lane 4), 4 hrs (lane 5), and 5 hrs (lane 6) after the IPTG 
induction. The prestained molecular weight standard (lane 7) was applied. 
(B), Western blot of(A). (C), The yield(%) of the GST-QPsl fusion 
protein against total cellular proteins at each induction length was 0, 6.5%. 
7.8%, 8.3%, 8.5%, and 8.75%, respectively. 
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degraded by proteases when expressed in microorganisms, in the form of inclusion bodies 
may offer a possibility to stabilize the protein ( 12 ). However, recovery of active 
recombinant protein from the inclusion body complexes has long been regarded as a 
formidable task due to the denaturation of the protein and the heterogeneous nature of 
inclusion bodies ( 1 ). Although general techniques for obtaining active recombinant 
protein from inclusion bodies have not been developed, some success has been reported 
(11, 13). In these cases, recombinant protein aggregates were solubilized with a high 
concentration of urea or other chaotropic reagents, and dialyzed to allow proper refolding 
of the protein structure (11, 13). 
Solubilization of recombinant GST-QPsl fusion protein from inclusion body 
precipitates was achieved by the urea-dialysis method. The inclusion body precipitates 
were suspended with 100 mM Tris-Cl, pH 7.4, containing 8 M urea to give the final 
concentration of urea of about 5 to 5.5 M. DTTwas added to the urea-treated suspension 
to give a final concentration of 1 mM. After stirring for 30 min at room temperature, the 
mixture was centrifuged at 16,000 x g for 20 min. About 60% of the fusion protein in 
inclusion body complexes was recovered in the soluble fraction. The urea-solubilized 
inclusion body complexes were dialyzed against I-liter of 50 mM Tris-Cl buffer, pH 7.4, 
containing 0.2% sodium cholate overnight with four changes of buffers. The dialyzed 
solution was centrifuged at 16,000 x g for 20 min to remove insoluble precipitates formed. 
About 20% of the recombinant GST-QPsl fusion protein in urea..;solubilized inclusion 
body fraction remained in soluble form after dialysis. The inclusion of0.2% sodium 
cholate in the dialysis buffer slightly increased the yield of soluble GST-QPsl fusion 
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protein upon dialysis of the urea-solubilized inclusion body fraction. Thus, the recovery of 
soluble recombinant GST-QPsl from inclusion body by the urea-dialysis method was 
about 12%. 
Isolation and Properties of Purified Recombinant OPsl 
Scheme IV outlines the protocol for isolation of recombinant QPs 1 from E. coli 
DH5a/pGEX/QPsl cell culture. Pure GST-QPsl fusion protein was obtained from both 
crude soluble extract and solubilized inclusion body fraction by glutathione agarose gel 
chromatography (see Experimental Procedures), indicating that GST-QPsl fusion protein 
in both two fractions possessed a properly folded GSH active site which was capable of 
binding to glutathione agarose. 
The recombinant QPsl was released from purified GST-QPsl fusion protein by 
thrombin cleavage. When purified GST-QPsl was incubated with thrombin (0.005 
unit/ µg of protein) at room temperature, QPsl was progressively released from GST, with 
about 90 % being cleaved in a I-hour incubation (Fig. 17). However, the cleavage of 
QPsl from GST by thrombin never reached completion, even after prolonged incubation 
with increased amount of thrombin. The reason for this is unknown. The released GST, 
uncleaved GST-QPsl fusion protein, and thrombin in thrombin-treated mixture were 
removed by Superose-12 FPLC column chromatography. Tue purified recombinant QPsl 
was recovered in the column's void volume, indicating that the protein was in the highly 
aggregated form. The aggregation of QPsl in aqueous solution results from the presence 
of three transmembrane helices in the protein (3). Although inclusion of 0.01 % of 
Scheme IV. The Protocol for Isolation of the Recombinant QPsl Protein :fromE. coli 
DH5a Cells Containing pGEX/QPsl. 
overnight grown 
DH5a/pGEX-QPsl 
Bacterial growth media 
1-IPTG induction - Harvest 
( Cell Paste ) 
-PMSF 
- Sonication 
-Triton X-100 
- Centrifugation 
( Crude Extract ) ( Inclusion body ) 
- GSH-agarose gel 
1111111~1i~1:111~11m1~111111 
- Solublization 
(Urea I Dialysis) 
1 -Digestion by Thrombin 
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Figure 17. SDS-PAGE of the Isolated GST-QPsl Before and After Cleavage By 
Thrombin. 20 µl of the fusion protein (7. 9 mg/ml) was diluted in thrombin 
digestion buffer (20 mM Tris-Cl, 150 mM NaCl, 25 mM CaCli, pH 8.0) to 
a protein concentration of0.5 mg/ml and thrombin (0.005 unit/ µg 
protein). n-Dodecyl maltoside (15 %) was included to a final concentration 
of0.01%. Thrombin (0.005 unit I µg protein) was added to the sample 
solution. Before (line 1), 10, 30, 60, 120, 240 and 360 minutes (line 2 to 7, 
respectively) after incubation with thrombin, 20 µ1. of digested solution was 
withdrawn, treated with sample buffer containing 1 % SDS and 1 % 13-ME, 
and subjected to SDS-PAGE. 
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dodecylmaltoside in the thrombin digestion mixture and in the buffer system during 
subsequent column chromatography did not prevent QPsl from aggregation upon removal 
ofGST, the recombinant QPsl thus obtained was in detergent-dispersed form The 
apparent molecular weight of recombinant QPsl in 50 mM Tris-Cl buffer, pH 8.0, 
containing 150 mM sodium chloride and 0.01% dodecylmaltoside was over one million. 
When the QPsl containing :fraction recovered from Superose-12 column was subjected to 
SDS-PAGE, a band corresponding to the third subunit (QPsl) of purified SQR was 
observed. 
Reconstitution of the Cytochrome bs6o-Containing GST-OPsl Fusion Protein by Heme 
Although QPsl is believed to be cytochrome bs6o, with a bis-histidine ligand (16), 
isolated recombinant QPsl, obtained either from the crude soluble :fraction or from 
inclusion body complexes, contained little cytochrome bs6o heme. The possibility exists 
that lack of cytochrome bs6o heme in recombinant QPsl results from the inability of E .. 
coli DH5a/pGEX-QPsl cells to produce enough heme to be ligated into the QPsl moiety 
in expressed GST-QPsl fusion protein. In other words, the QPsl in expressed GST-QPsl 
fusion protein has the correct protein configuration for heme ligation and the two histidine 
residues of the ligand for cytochrome bs6o are from QPsl protein. One way to test this 
possibility is to reconstitute cytochrome bs6o from recombinant QPsl by heme. Although 
reconstituted bs6o-containing QPsl could be prepared by addition of heme to purified 
recombinant QPsl or to recombinant GST-QPsl followed by thrombin cleavage, the latter 
was chosen because GST-QPsl fusion protein was soluble in aqueous solution and 
exhibited as monomer form whereas isolated recombinant QPsl was in a highly 
aggregated form 
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Figure 18A shows the restoration of cytochrome b560 to GST-QPsl at the expense 
of added heme. When hemin chloride in DMSO was added to the fusion protein in 50 
mM Tris-Cl buffer, pH 8.0, containing 0.25M sucrose, at 0.24 mole ofheme per mole of 
fusion protein, the maximum absorption peak of oxidized form of the heme was 
progressively shifted from 398nm to 411 nm with increasing absorption intensity as 
incubation time increased. It took two hours to complete the spectral red shift and reach 
maximum increase in absorption intensity. When the reaction was complete, dithionite 
was added to reduce the sample. The reduced sample showed a symmetrical a-absorption 
at 559.5 nm, a broad B-absorption peak at 530 nm, and Soret absorption at 425 nm 
These absorption characteristics were identical to those of cytochrome b560 in isolated 
reconstitutively active QPs preparation. They differed completely from reduced free heme 
spectra (see Fig. 18B). These results indicated that cytochrome b560 was reconstituted 
from recombinant GST-QPsl fusion protein. 
Restoration of cytochrome b560 to GST-QPsl was heme concentration dependent. 
When a constant amount ofisolated recombinant GST-QPsl was incubated with various 
concentrations ofhemin chloride, the peak height at 560 nm increased as the 
concentration of heme increased (Fig. 19A). Maximum increase of the peak height at 560 
nm was obtained when 0.5 mole of heme per mole of fusion protein was used (see Fig. 
19B). However, the amount ofheme being ligated into the GST-QPsl protein to form 
cytochrome bs6o was less than 0.5 mole of heme /mol protein because the difference 
Figure 18. Restoration of Cytochrome bs6o from Isolated Recombinant GST-QPsl 
Fusion Protein and Heme. (A), 3µ1 ofhemin chloride (6.18 mM) in DMSO 
was added to 1ml of isolated GST-QPsl fusion protein (3.1 mg/ml), and 
incubated at room temperature until no more change in oxidized Soret 
absorption peak ( ). The isolated GST-QPsl was in 50mM Tris-Cl 
buffer, pH 8.0, containing 0.25 M sucrose. Total incubation time was 
about 2hrs. The molar ratio of the added heme to the fusion protein was 
0.24: 1 and the concentration ofDMSO in the mixture was 0.3 %. When 
the reaction complete, the sample was reduced by dithionite (------). Heme 
concentration was determined by pyridine hemochromogen spectrum for 
free heme and difference spectra for heme in the protein. Oxidized form of 
the fusion protein is shown, too (- ____ ). (B), Absorption spectra of 
oxidized and reduced form of free heme. The same amount ofhemin-
chloride as (A) was added to 1 ml of the sample buffer. The inset in each 
panel shows difference spectrum of dithionite reduced minus oxidized form 
at a absorption region. 
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Figure 19. Difference Spectra of Reconstituted Cytochrome bs6o From Isolated 
Recombinant GST-QPsl and Various Amount of Heme. (A), Difference 
spectra of dithionite reduced minus oxidized reconstituted cytochrome bs6o 
were obtained when 1ml of isolated GST-QPsl ( 0.3 mg/ml)was incubated 
for 2 hour at room temperature with various amount ofhemin chloride in 
DMSO. The molar ratios of heme to the fusion protein were O (line 1 ), 
0.25 (line 2), 0.5 (line 3), 0. 75 (line 4), 1 (line 5), and 2 (line 6) mole of 
heme I mole protein, respectively. The concentration of DMSO in the 
sample was kept lower than 0.3%. (B) Difference spectra of the two 
neighboring spectra of(A) in a absorption region. The numbers shown in 
(B) indicates those of spectra in (A). 
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spectra between ditbionite reduced, 0.5 mole heme added GST-QPsl mixture and 0.25 
mole heme added GST-QPsl mixture showed a small broad shoulder peak at 575 nm (see 
Fig. 19B) corresponding to reduced free heme a-absorption peak (see Fig. 18B). The 
amount of cytochrome bs6o reconstitution may directly correlate to the amount of intact 
GST-QPsl present in the isolated fusion protein preparation. The recombinant fusion 
protein purified from soluble cell extract was often contaminated with a 68 KDa-molecular 
mass protein and some degradative products ofGST-QPsl fusion protein, as shown in 
lane 5 of Figure 20C. About 40.5% of total protein in this GST-QPsl preparation was 
intact GST-QPsl fusion protein. This was estimated by comparing the color intensity of 
the 41-kDa protein band (GST-QPsl fusion protein), which reacted with antibodies 
against QPsl, with that of total protein bands in SOS-PAGE of fusion protein preparation. 
Assuming that only intact GST-QPsl fusion protein is capable of ligating with heme to 
form cytochrome bs6o, then this reconstituted sample must contain about 0.38 mol bs6o 
heme per mol of fusion protein. 
It was reported (8) that reduced cytochrome bs6o in SQR had a-absorption at 
560.5 nm with a shoulder at 553 nm and was completely not reactive toward carbon 
monoxide (CO), whereas reduced cytochrome bs6o in QPs had a symmetrical a-
absorption at 560 nm and was reactive to CO. Addition of reconstitutively active SDH to 
QPs converts cytochrome b56Q from CO reactive to CO non-reactive and causes the 
reappearance of the 553 nm a shoulder peak. Figure 20 compares absorption spectra and 
CO reactivity of the reconstituted cytochrome bs6o in recombinant GST-QPsl fusion 
protein in the presence and absence of SDH. As shown in Figure 2 lA, reduced 
Figure 20. FPLC Chromatogram with A21s and A 560 Obtained From Isolation of Heme-
Reconstituted Recombinant QPsl from GST-QPsl Fusion Protein By 
Thrombin. 2 ml ( 6.2 mg) of heme-reconstituted recombinant GST-QPsl 
(0.13 mole ofheme I mole protein) was diluted with the same volume of 
thrombin digestion buffer (20 mM Tris-Cl, pH 8.0, containing 150mM 
NaCl, 25mM CaCh) and n-dodecylmaltoside (15 %) was added to a final 
concentration of0.01 %. The diluted sample was incubated for 1hr at 
room temperature with thrombin (0.005 unit/µg protein). The thrombin 
treated sample was concentrated to 0.5 ml and applied to the Superose 12 
FPLC column equih"brated with 50 mM Tris-Cl buffer, pH 8.0, containing 
150 mM sodium chloride and 0.01% n-dodecyl maltoside. The fraction 
was collected with 4 mini tube at a flow rate of0.5 ml/min. The protein 
concentration was detected at 278nm (A) and the cytochrome b560 
concentration was profiled (B ). Twenty five-µI of each from fraction 4 to 
7 (lane 1-4), isolated GST-QPsl (lane 5), SQR (lane 6), and prestained 
molecular weight standard (lane 7) were subjected to SDS-PAGE (C) and 
Western Blot (D ). 
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Figure 21. Absorption Spectra and CO Reactivity of Cytochrome b560 in Heme-
Reconstituted Recombinant GST-QPsl in Presence or Absence ofSDH 
For spectral analysis, a divided cell, which is composed of two 
compartments, and in which the two samples can be mixed by gentle 
shaking, was used. One compartment contains 1ml ofGST-QPsl 
(1.5 mg/ml) containing 0.02% n-dodecyl maltoside and the other one 
contains 1ml of0.1 M sodium/potassium phosphate buffer, pH 7.8, 20 mM 
sodium succinate, reconstitutively active SDH (3.5 mg/ml), or 
reconstitutively inactive SDH (3.5 mg/ml), respectively. For reference cell, 
the two solutions were kept separated and for sample cell, the two 
solutions were mixed, incubated for 30 min on ice, reduced by dithionite, 
and treated with CO. Absorption .spectra of cytochrome after reduction 
(------- ) and treatment with CO ( __ ) were obtained against the 
reference cell which had the same composition in each compartment as that 
of the sample cell. The reconstitutively active SDH was dealed undered 
anaerobic condition (under argon) and the reconstitutively inactive SDH 
was prepared by incubating the reconstitutively active SDH under aerobic 
condition for 2 hrs on ice. Absorption property and CO reactivity of 
cytochrome b560 in heme-reconstituted recombinant GST-QPsl only (A) 
were compared with those in presence of reconstitutively inactive SDH (B) 
or active SDH (C). (D), Difference spectrum of CO reactivity in (C) 
minus that in (B ). 
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reconstituted cytochrome bs6o in recombinant GST-QPsl fusion protein had a 
symmetrical a-absorption peak at 560 nm without the shoulder peak at 533 nm and totally 
reactive to carbon monoxide. Addition of reconstitutively active SDH to the heme-
reconstituted fusion protein did not convert reconstituted cytochrome b560 from CO 
reactive to CO non-reactive ( see Fig. 2 IB ). As expected, no restoration of succinate-Q 
reductase was observed by this reconstitution. The failure to observe the interaction 
between SDH and reconstituted cytochrome bs6o in GST-QPsl, through the detection of 
absorption spectral change and CO reactivity, may be due to the presence of GS T in the 
NH2-terminus of QPsl or to the requirement of QPs2 or QPs3 for this interaction. 
Although cytochrome bs6o spectral characteristics were restored to GST-QPsl fusion 
protein upon addition of heme, it was not known whether the two histidjnes for liganding 
of cytochrome bs6o were both from GST, or QPsl, or one from GST and one from QPsl 
moiety of the fusion protein. GST contains 6 histidines and QPsl has 7 histidines. 
It was reported that BSA had binding affinity toward heme (17, 18). We observed 
ab-type cytochrome spectrum when heme was added to BSA (see Fig. 22). When heme 
in DMSO was added to bovine serum albumin (BSA) in 50 mM Tris-Cl buffer, pH 8.0, 
containing 0.25 M sucrose, a red shift of the soret absorption from 386 nm to 400 nm was 
observed. The absorption intensity at 400 nm decreased as incubation time increased and 
dithionite-reduced sample showed a absorption peak at 558 nm, J3-absorption at 531, and 
Soret absorption at 422 nm It should be noted that BSA contains 16 histidine residues. 
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Figure 22. Absorption Spectra During Incubation of BSA with Heme and After Reduction 
By Dithionite. 1ml of BSA ( 2 mg/ml), in 50mM Tris-Cl buffer, pH 8.0, 
containing 0.25 M sucrose, was treated with hemin chloride 
( 0.25 mole of heme I mole protein). The mixture was incubated at room 
temperature until no further change in oxidized Soret absorption peak 
( __ )was observed. Total incubation time was about 2 hrs. At the end 
of incubation the sample was reduced by dithionite (------). The inset in 
each panel shows the difference spectrum of dithionite reduced minus 
oxidized form at a absorption region. 
91 
Isolation of bs6o heme-containing OPsl 
The observation of reconstitution of ab-type cytochrome in a solution of BSA to 
which heme has been added raised the posst"bility that the observed cytochrome bs6o 
spectra in a solution ofGST-QPsl fusion protein to which heme has been added might 
resuh from heme ligation through histidine residues in the GST moiety of the GST-QPsl 
fusion protein. On the other hand, the recent report of the bis-histidine ligand of 
cytochrome bss6 of E. coli SQR being contributed by histidines from each sdh C and sdh 
D gene products (19) increased the possibility of involving both GST and QPsl moieties 
in bs6o heme ligation observed in cytochrome bs6o-restored GST-QPsl fusion protein. 
To determine the origin of histidine residues involved in heme ligation in cytochrome bs6o 
reconstituted GST-QPsl fusion protein, the reconstituted fusion protein was treated with 
thrombin and subjected to Superose-12 FPLC column chromatography separation of 
proteins. Figure 20A shows Superose-12 FPLC column profile of thrombin-cleaved, 
heme-reconstituted GST-QPsl fusion protein. To avoid the complication resulting from 
the presence of free heme in reconstituted samples, 0.25 mole ofheme was added per 
mole of recombinant GST-QPsl fusion protein during reconstitution. The majority of 
reconstituted cytochrome bs6o was found in a fraction eluted at the void volume of the 
column (see Fig. 20B). SOS-PAGE analysis of column fractions (Fig. 20C) confirmed 
that this bs6o heme containing fraction was the QPsl containing fraction. The QPsl 
containing column fraction showed absorption characteristics (Fig. 23) identical to that 
observed in heme-reconstituted GST-QPsl fusion protein, indicating that QPsl is 
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Figure 23. Absorption Spectra of cytochrome bs6o in the Two Fractions Eluted from 
FPLC Chromatography. Absorption spectra of oxidized ( -- ) and 
reduced (------)cytochrome bs6o ofisolated fraction 4 (A) and 7 (B) were 
detected. The inset shows difference spectrum of dithionite reduced minus 
oxidized cytochrome bs60-
responstl>le for heme ligation of cytochrome bs60· Since QPsl contains seven histidine 
residues, which are the two hitidines involved in heme ligation is currently under 
investigation in our laboratory by using the site-directed mutagenesis approach. 
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CHAPTER IV 
CLONING AND SEQUENCING OF cDNA ENCODING QPs2 
OF SUCCINATE-UBIQUINONE REDUCTASE 
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While participation of QPsl in Q-binding of SQR is established, the involvement of 
QPs2 and QPs3 in providing the Q-binding site is rather uncertain. When a Q-deficient, 
succinate-free SQR was photoaffinity labeled with [3H]azido-Q derivatives, some of the 
radioisotope labels were detected in QPs2 and QPs3 (Chapter II) although the majority 
was found in QPsl. The radioactivities QPs2 and QPs3 were about 45% and 50% of that 
observed in QPsl. This lower azido-Q uptake by QPs2 and QPs3 may result from 
portions of the Q-binding sites being contributed by these two subunits, or from the 
preferential occupation of these two subunits by the endogeneous Q present in the 
partially Q-deficient SQR. One way to test the Q-binding role of QPs2 and QPs3 is to 
attempt to isolate a [3H]azido-Q linked peptide from [3H]azido-Q labeled QPs2 or QPs3 
obtained from [3H]azido-Q labeled, Q-depleted SQR. However, identification ofQ-
bidning domains in QPs2 and QPs3 requires knowledge of the amino acid sequences of 
both subunits. It is best to obtain these two protein sequences by nucleotide sequencing 
because peptide sequencing of these proteins is experimentally difficult due to their 
resistance to proteolytic enzyme digestion. 
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In this chapter, I report the isolation of pure QPs2, production and purification of 
antibodies against QPs2, imtmmological screening of a bovine heart cDNA expression 
library i1i 11.gtll to ·obtain a cDNA clone for QPs2, and nucleotide sequencing of five 
possible cDNA clones obtained for QPs2. 
Experimental Procedures 
Materials 
Bovine serum albumin, DCPIP, Triton X-100, and sodium cholate were obtained 
from Sigma. Goat anti-rabbit IgG-aJkaJine phosphatase conjugate, protein A-horseradish 
peroxidase conjugate, SOS-PAGE molecular weight standards, alkalitte phosphatase 
substrate kit, and DEAE Affi-Gel blue were purchased from Bio-Rad. Phenyl sepharose 
CL-4B and sephacryl S-300 SF were obtained from Pharmacia. Calcium phosphate was 
prepared according to Jenner ( 1 ), and mixed at a 3: 1 ratio with cellulose powder prior to 
use i1i column chromatography. 
Restriction endonucleases were obtained from either Promega Corporation or 
Bethesda Research Laboratories, Inc. Beefheart cDNA expression library i1i 11.gtl l was 
from Clontech. T4 DNA ligase were from Promega. DNase I, Type IV, RNase A, IPTG, 
X-gal, gelatin, BCIP, and NBT were from Sigma. TA cloning kits were from Invitrogen 
and Erase-a-Base System was from Promega. LB agar and LB broth base were from 
GIBCO. Nitrocellulose disks were from Schleicher & Schuell. PVDF membranes were 
from Millipore. Other chemicals were obtained commercially i1i the highest purity 
available. 
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Bacterial Strains, Phages, and Plasmids 
E. coli Y1090r[..MacU169A(lon, araD)139 strA supF(trpC:TnlO)] was used as 
host for plaque screening and propagation of A.gt 11 recombinations. E. coli 
JM109[recAl, endoAl, gyrA96, thr, hsdR17, supE44, re/Al A(lac,pro)FtraD36proAB 
laclq, lacZ Ml5] was used as host for pGEM-3Zf(+) and pGEM-5Zf(+) plasmids. These 
plasmids, which were used for subcloning and sequencing, were obtained from Promega. 
E. coli strains were grown in LB medium (2). When necessary, MgS04 (lOmM), maltose 
(0.2%), and ampicillin (100 µg/ml) were added. 
Isolation of Pure 0Ps2 Protein 
Submitochondrial particle (3), SCR ( 4), and SQR (5) were prepared according to 
methods reported previously. QPs was prepared from SQR by a Phenyl sepharose CL-4B 
(Pharmacia) column chromatography with different buffer systems. SQR obtained from 
the second calcium phosphate-cellulose column was diluted to 2 mg/ml with 50 mM Tris-
Cl buffer, pH 7.4, containing 0.2 % sodium cholate, and incubated for 30 minutes at room 
temperature with stirring. The mixture was applied to a Phenyl sepharose CL-4B column 
equih"brated with 50 mM Tris-Cl buffer, pH 7.4, containing 0.2 % sodium cholate. The 
column was washed stepwise with three column volumes of each washing buffer. The 
washing buffers were 50mM Tris-Cl buffer, pH 7.4, containing 0.2 %, 1 %, 2 % sodium 
cholate, and 2 % sodium cholate with 4M urea. The crude QPs was eluted with 50 mM 
Tris-Cl, pH 7.4, containing 0.2 % SDS. Crude QPs was treated with 1 % SDS and 1 % 
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P-mercaptoethanol and subjected to high resolution SDS-PAGE. The QPs2 containing 
band was excised from the gel. Pure QPs2 was obtained by electrophoretic elution of the 
QPs2 containing gel slices. The purity of eluted QPs2 was confirmed by SOS-PAGE. 
Production and Purification of AntJ."bodies Against 0Ps2 
Pure QPs2 was concentrated to about 3 mg/ml with Centricon-10, and precipitated 
by 50% acetone at 0°C. This treatment removed most of SDS and other water-soluble 
contaminants. The precipitate was washed once with H20, flushed with argon to remove 
the remaining acetone, and suspended in H20. The mixture was centrifuged for 1 hour at 
150,000 x g to remove any water-soluble impurities and the trace acetone remaining in the 
solution. The precipitate thus obtained was suspended in H20 to a protein concentration 
of2 mg/ml. QPs2 suspension (0.5 ml) was emulsified with an equal volume ofFreund's 
complete adjuvant and subcutaneously injected into a rabbit subcutaneously. Boosters of 
QPs2 (0.5mg) were given weekly for one month, blood was collected by cardiac puncture, 
and serum was obtained after clotting. 
Antibodies against QPs2 were purified at 0-4 °C as descn"bed (7). Sera were 
brought to 50 % ammonium sulfate saturation with a neutralized saturated ammonium 
sulfate solution and centrifuged at 28,000 x g for 30 min. The precipitate was dissolved in 
20 mM Tris-HCI, pH 8.0, containing 50 mM NaCl, and dialyzed against this ~e buffer. 
The dialyzed solution containing IgG was applied to a DEAE Affi-Gel blue column ( 5 
times the serum volume) equilibrated with 20 mM Tris-HCI, pH 8.0, containing 50 mM 
NaCl. The effluent containing IgG was collected and concentrated by ultrafiltration with 
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an Amicon PM-30 membrane. IgG was further purified on a Sephacryl S-300 SF column 
equilibrated with phosphate buffer saline (PBS) to remove the contaminating IgM. IgG 
fraction was concentrated by ultrafiltration with Amicon PM-30 membrane to give a 
protein concentration of around 5 mg/ml. Sodium azide was added to give a final 
concentration of0.02 %. Samples were frozen at -80°C until use. 
DNA Manipulation 
Restriction enzyme digestion, large-scale isolation and minipreparation of plasmid 
DNA, isolation and purification oflamda phage DNA were performed according to 
reported :m,ethods (2) 
Immunological Screening of a Bovine Heart cDNA Library with Antibodies Against 0Ps2 
The beef heart cDNA expression library in )..gt 11 was immunologically screened 
with antibodies against QPs2, using E. coli Yl090r- as host, essentially according to the 
method described previously (8, 9). Antibodies against QPs2 (30 µg/ml) were 
preincubated with E. coli lysate ( a final protein concentration of lmg/ml ) for I hour at 
room temperature. This E. coli lysate treated anti-QPs2 antibodies were used as the 
primary antibody and Goat anti-rabbit IgG alkaline phosphatase conjugate was the 
secondary antibody. BCIP and NBT were used for as substrates to detect alkaline 
phosphatase activity. 
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DNA Sequencing 
DNA sequencing was performed in our lab by the dideoxy method of Sanger ( 10) 
or at the Recombinant DNA/Protein Resource Facility at Oklahoma State University. The 
sequencing primers used were the T7, SP6 promoter primer, M13 forward, and M13 
reverse which were obtained from Promega or synthesized by the Recombinat 
DNA/Protein Resource Facility at Oklahoma State University. The cDNA fragments 
generated from restriction enzyme digestion of QPs2 cDNA were sub cloned into pGEM 
3Zf(+) or pGEM-5Zf(+) plasmid (from Promega) and sequenced. 
Electro blotting of 0Ps2 Protein onto a PVDF Membrane for Microsequencing 
SQR was treated with 1 % ,8-mercaptoethanol and 1 % SDS for 2 hrs at 37 °C. 
Twenty-µl aliquots of the SDS and ,8-ME treated samples were applied to wells of an 
SOS-PAGE gel which had been pre-electrophoresed for overnight at 45 V with an anode 
buffer containing 0.2 M Tris-Cl, pH 8.9, and 0.1 mM sodium thioglycolate and a cathode 
buffer containing 0.1 M Tris, 0.1 M Tri.cine, 0.1 % SDS, and 0.1 mM sodium 
thioglycolate, pH 8.2. The proteins in SOS-PAGE gel were electroblotted to a PVDF 
membrane according to the procedure of LeGendre et al. ( 6) with CAPS transfer buffer 
( 10 mM CAPS, 10 % methanol, pH 11) for 15 min . After the transfer was complete, the 
membrane was rinsed several times with HPLC-grade H20 and stained with Coomassie 
blue R-250 (0.1 % in 50 % methanol) for 2 min to visualize the proteins bound to the 
membrane. The blue band corresponding to QPs2 protein was cut out and subjected to 
NHi-terminal sequence analysis. 
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Isolation of 0Ps2 protein for Amino Acid Sequencing 
The conditions for SOS-PAGE ofSQR were the same as those described in 
microsequencing. The QPs2 band in SOS-PAGE gel was excised and the protein was 
electrophoretically eluted from the gel slices. The eluted QPs2 was concentrated by 
membrane filtration with Centricon-10. The sample was washed several times with H20 
and concentrated to about 2 mg/ml to remove all the small molecular weight impurities 
which have absorbance at 278 nm. The concentrated QPs2 was precipitated with 50 % 
cold acetone (-20 °C) to remove SOS in the sample. The sample was air-dried to remove 
the residual acetone and subjected to peptide sequencing. 
Amino Acid Sequence Determination 
Amino acid sequence analyses were done at the Molecular Biology Resource 
Facility, Saint Francis Hospital of Tulsa Medical Research Institute, University of 
Oklahoma Health Sciences Center, under the supervision of Dr. Ken Jackson. 
Results and Discussion 
Immunological Specificity of Antibodies against 0Ps2 
When the immunological specificity of antibodies against QPs2 was characterized 
by W estem blotting using QCR, SCR, SQR, E. coli SQR, E. coli lysate, and isolated 
QPs2 as antigens, no binding was found with SDH moiety of SQR, E. coli SQR, QPsl, 
and QCR However, anti-QPs2 antibodies reacted with E. coli lysate and QPs3, in 
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addition to QPs2, suggesting that anti-QPs2 antibodies contained other IgGs which can 
react with E. coli cellular proteins and QPs3. The reason for the cross-reactivity of anti-
QPs2 antibodies with QPs3 could be that the preparation of QPs2 was contaminated with 
QPs3 or QPs2 and QPs3 had common epitopes. However, when the antibodies were 
treated with E. coli lysate before using them in Western blotting, the cross-reactivity of 
the antibodies with both E. coli lysate and QPs3 disappeared (Fig. 24 ), implying that the 
cross-reactivity mainly came from non-specific binding with E. coli cellular proteins, some 
of which might have the same epitope as QPs3. Therefore, preincubation of anti-QPs2 
antibodies with E. coli lysate prior to use for screening a beef heart cDNA library was 
necessary. 
Isolation of a cDNA Encoding 0Ps2 from Beef Heart cDNA Expression Library in Agtl 1 
1.5 x 106 plaques of the beef heart cDNA expression library in Agtl 1 were 
screened with anti-QPs2 antibody. Four positive clones with the highest signal intensity 
were isolated and purified. The cDNA inserts were excised from recombinant phage DNA 
by digestion with EcoRI and subcloned into pGEM-3Zf{ +) or amplified with PCR and 
subcloned into pCR II by using the TA cloning kit (Invitrogen). The approximate 
molecular sizes of the inserts were 0.9, 0.85, 0.65, and 0.45 kb. 
This beef heart cDNA library had previously been screened for QPs2 cDNA clones 
with anti-QPs2 antibodies which were prepared by using QPs2 protein. Antigen had been 
obtained from SOS-PAGE system ofLaemmli (11) in the presence of7 M urea. 
Preincubation of antibody with E. coli lysate was not included during the screening. 
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Figure 24. Western Blot Analysis of Antibodies Against QPs2. (a), SOS-PAGE of the 
pre steined molecular weight standard (lane 1 ), E.coli SQR (lane 2 ), E.coli 
lysate (lane 3), ubiquinol-cytochrome c reductase (lane 4), succinate-Q 
reductase (lane 5), QPs eluted from hydrophobic column (lane 6), and the 
isolated QPs2 (lane 7). The prestained protein molecular weight standard 
contains phosphorylase b (112,000), bovine serum albumin (84,000), 
ovalbumin (53,200), carbonic anhydrase (34,900), soybean trypsin inhibitor 
(28,700), and lysozyme (20,500). SOS-PAGE was carried out according 
to the method of Schagger et al. containing 8 M urea in the separating gel 
(B), Western Blot of the proteins on gel (A). 
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One possible clone was isolated which had 1.1 kb ofits insert size. For nucleotide 
sequencing of this clone, two EcoRI-Hincil fragments were subcloned into pGEM-3Zf{+), 
and unidirectional deletions with Erase-a-Base System (Promega) (12) were generated. 
Screening this beef heart cDNA library for QPs2 cDNA clones by a hybridization 
method had also been tried. Degenerate oligonucleotides were designed from the reported 
partial NH2-terminal sequence (-SDSKAASL-) (14) or the partial sequence ofa trypsin-
digested peptide fragments (-AVAML-, -WTGER-) ofQPs2. Unfortunately, no 
reasonable clone was obtained. Although several clones were found to have a part of th~ 
NHrterminal sequence, -S-D-S-, all of them resulted from false priming. Possible reasons 
for failure of obtaining a QPs2 cDNA by this hybridization method are: (a) the 
oligonucleotides have high degeneracy and are too short; (b) the partial peptide sequence 
of trypsin-digested fragments and the NH2-terminal sequence are not ofQPs2 peptides, 
but of contaminants. Isolated QPs2 is highly aggregated and may not be suscepttl>le to 
protease digestion even after reductive carboxymethylation. The NH2-terminal sequence 
for QPs2 reported by Cochran et al.(13), which is the same as that of QPs3, may be a 
result of contaminanation by QPs3. 
The Nucleotide and Amino Acid Sequences Analysis of Obtained 0Ps2 cDNA clones 
Figure 25-29 show the nucleotide and amino acid sequences of the five posSI"ble 
QPs cDNA clones obtained from the two rounds of immunological screening of the beef 
heart cDNA hl>rary in 11.gtll with anti-QPs2 antibodies. The 0.9 kb insert has one possible 
ORF which codes 102 amino acids to give QPs2 molecular weight of 11,351 Da and a 
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GAATTCGGGC GCGGGAGTAA ACAGCCCGAT CTGGGAAAGT GGAGCTGTGG CCACGTCCGG 
GTGCTGCAGG GCAGCGGCGG AGACGACGCA GGCCTATCCT CGGTGGCCGA C 
112 ATG ACG GCC GCG GAT CAG AGC CCC CTG GCA CCG CTG TTG GAG ACT TTG GAA 
1 M T A A D Q s p L A p L L E T L E 
GAC CCT TCC GCC TCC CTT GGA GAG CAG ACC GAC GCT TAC CTG ACC CTG ACC 
18 D p s A s L G E Q T D .A y L T L T 
AGT CGT ATG ACT GGA GAA GAT GGA AAA GAA ATC ATT ACA GAA ATT GAG AAA 
35 s R M T G E D G K E I I T E I E K 
AAA CTT CCT CAG CTA TTT AAA GTT TTA AAG ACT CAC ATT GCC AGT CAA AAC 
52 K L p Q L F K V L K T H I A s Q N 
TCA GAC TCT AGA GGA CCC CGG GTA CCG AGC TCA GTA GTG CTG CTC TAC AGG 
69 s D s R G p R V p s s V V L L y R 
CCT TGG GGT TTT GCT TAT ATA ATC CCA AAA TTG CCT CTG GAT TAT CAG AGA 
86 p w G F A y I I p K L p L D y Q R 
TAA 
* 
ATATTCAAGA ACTGCTTTCA AAACTGAATG ATATTGTTAA AAGTTCAGAT AAAAATGTAC 
GTACTAGGGC ACTTTGGGTG ATATCCAAGC AGACGTTTCC CACTGAAGTC GTTGGCAAAG 
TAGTTTCTAG TATCATTGAC TCACTAGAAA TAGTATTTAA TAGAGGAGAG 
479 ATG CTT TCT GCT GTT GTG GAT TAT GAA GCA TTA AAT GTC ATT ATA AGA CTA 
1 M L s A V V D y E A L N V I I R L 
ATT GAA CAA GCC CCA GTT CAA ATG GGA GAA GAG TCA ATT AGG TGG GCA AAA 
18 I E Q A p V Q M G E E s I R w A K 
TTG GTC ATA CCT TTA CTG GTT CAT TCA GCC CAA AAA GTA CAT TTG CGG GGA 
35 L V I p L" L V H s A Q K V H L R G 
GCC ACT GCT CTA GAG ATG GGA ATG CCT TTG TTG CTT CAG AAA CAG CAA GAA 
52 A T A L E M G M p L L L Q K Q Q E 
ATA GCA TCT ATC ACA GAG CAG CTT ATG ACT ACC AAA TTA CTT TCA GAA CTC 
69 I A s I T E Q L M T T K L L s E L 
CAG AAA CTG TTT ATG AGT AAA AAT GAG ACT TAT GTG TTA AAA TTG TGG CCT 
86 Q K L F M s K N E T y V L K L w p 
TTA TTT GTC AAA CTT CTC GGG AAG CCC CCG AAT TC 
103 L F V K L L G K 
500 
3 3 
2 2 
1 1 
-1 
-1 
-2 
-2 
-3 
-3 
500 
Figure 25. Nucleotide Sequence and ORF Map ofa cDNA (0.9 kb insert) Encoding 
Bovine QPs2 and Deduced Amino Acid Sequence of Possible ORF. 
1 
61 
101 
1 
152 
18 
203 
35 
254 
52 
305 
69 
356 
86 
401 
461 
521 
581 
641 
701 
761 
821 
881 
GAATTCGGGC AGTTGTTCCC CCGGAGCTCT GGGAACATTG CCCTGCCTGA CAACATTCTT 
GTCTGGGCAA GGGCAGTGTG ACCTTGAGTG GCACTTGCCA 
ATG GGC CTC 
M G L 
GGT CAT GGC 
G H G 
CTG CCT 
L p 
CCT GCC 
p A 
GGT GAC CAC TTA TGT CCC TTG CAT TTT TCT ATC TGT 
G D H L C P L H F S I C 
TCC TTG CGA AGT CTG GCT CTG TTG AGG ACC TGT CTG 
S L R S L A L L R T C L 
GCA GAT GCC AGC GTC GGG GTC CAG GGC TCG TCT GGC CCT GGA GCA TCA TCA 
A D A S V G V Q G S S G P G A S S 
CAA GGT CTG GTG GGT ATG AAT ATG TCT GGT TCT CTG TCT ACC TGG AAG GAA 
Q G L V G M N M S G S L S T W K E 
GGA GGC AAC CAG GGG ACT GGT TCC CAG TCC TGG TTC CCA GCC TGC CCT GAG 
G G N Q G T G S Q S W F P A C P E 
GAT TCA GTC TCT TCT TGG GGT CAA GAA TGG ATT CCT GTG CAG TGA 
D S V S S W G Q E W I P V Q * 
ATCAGTCTTG GCTGTGACAG AGGAGGCCAG TCCTGATGAC CAAGATGAAT ATTCGCTGTG 
TCTGGGCCAA GAAATTAGAA CCTTTAGGTG GGCAGGAACA GAAGGTCCCA CCGGCACACA 
CAGTCCAGAG TCATGAAGAG AGTGAAGTGG AAAAGTTTCT GGGGGCTCAG CCTGGGGGGC 
AGATGCCAAA GTCAAAAGCA GTCAAAAGTC AAAAATTATG ACTTCCGTGG TAGTCCAGTG 
GTTAAGAATC TGCCTGCAGT GCCAGGGGAC ACGGGTTCCG ATTCCAGGTC CGGGAAGATC 
CCACATGCTG CAGGGTGACT AAGCTCGGAC ACCACGACCG CTGGGCCCAC ACTGGAGAGC 
CTGCAAGCTG TAACTGTTGA AGCCTGTCTG CCCACACACC ACAGTTAGAG AGTAGCCCCG 
GCTCGCTGCA ACTGGAGAAA GCCTGTGAGC AGCAATGAAG ACCCAGCACA GCCAAAAAAA 
TATTAAAAAA ATTTTAAGTT AA.AAAAAAAC CCGAATTC 
500 
3 3 
2 2 
1 1 
-1 -1 
-2 -2 
-3 -3 
500 
Figure 26. Nucleotide Sequence and ORF Map ofa cDNA (0.85 kb insert) Encoding 
Bovine QPs2 and Deduced Amino Acid Sequence of Possible ORF. 
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1 GAATTCGGGG GGAAGCAAGG GGGAAGGACA GATACTGATT GGCTCAGCAA GTGCCTTATG 
61 GGATCCATCA AACCATGCCC TAGAGGCTAG TTTTCTCTGT AGGTTACTTT TTTTTTCCTG 
121 CCAACCAGAA TCTATGGAAG TCTAGGGACA GTTTTTACTT TACGCTGTAT ATTTTCTAGC 
181 AGCTAGCATT ACAGTCTGGA GAAGGCAATG GCACCCCACT CCAGTACTCT TGCCTGGAAA 
241 ATCCCATGGA TGGAGGAGCC TAGTAGGCTT CAGTCCATGG GGTCACTAAG AGTTGGACAC 
301 GACTGAGCGA CTTCACTTTC ACTTTTGACT TTCATGCATT GGAGAAGGAA ATGGTAACTC 
361 ACTCCAGTGT TCTTGCCTGG AGAATCCCAG GGATGGGGGA GCCTGGTGGG CTGCCGTCTA 
421 TGGGGTCGCA CAGAGTCAGA CATGACTGAA GTGACTTAGC AGCAGTAGCA GCAGCATTAC 
481 AGTCAGTGCA CAACCAATAT TAGCTAATTA GTAGCTAGTA CAAGGTTATG CCCATGCAAT 
541 GCAAAAACTC TCTGCTTCAG TGGATGCTCT GTCTGCCTTC TTGGTTGTAC AGCATCCGAG 
601 CCACATCTCA CATTTTCTCC AAGACCCCTT ATTTGAAAAC AAAATGTTCA GCTTTAAAAA 
661 CTCTCTGCTT CAGTGGATGC TCTGTCTGCC TTCTTGGTTG TACAGCATCC GAGCCACATC 
721 TCACATTTTC CCCGAATTC 
500 
3 3 
2 2 
1 1 
-1 
-1 
-2 
-2 
-3 
500 
Figure 27. Nucleotide Sequence and ORF Map of a cDNA (0.65 kb insert) Encoding 
Bovine QPs2 and Deduced Amino Acid Sequence of Possible ORF. 
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1 GAATTCGGGC GCCAGCTGCA GCTGGGCGAG CGCTCCGTGC AGGAGGTGGC TGAGGTGGAA 
61 GCTGTGCGGC GGGCCCTGCG GGGCTCGGGT GTCATTGCAG GCGTGTGGCT TGAGGAGGCG 
121 AGGCAGAAAC TAAGCATTTA TGAGGCTCTG AAGAAAGAGT TGCTGCAGCC AGAGGCAGCT 
181 GTCGCCCTGC TCGAGGCCCA GGCTGGCACC GGGCATGTCA TCGACCCTGC CACCAGCGCA 
241 CGGGTGACTG TGGATGAGGC GGTGCGCGCC GGCCTGGTGG GCCCTGAGCT GCATGAGAAG 
301 CTGCTATCGG CCGAGAAGGC TGTGACTGGC TACAAGGACC CCTACTCAGG GGAGAGCGTG 
361 TCCCTGTTCC AGGCCCTGAA GAAGGGCCTC ATTCCCAGGG AGCAGGGCCT GCGTCTACTG 
421 GACGCCCAGC TGTCCACGGG GGGCATCGTG GACCCCAGCA AGAGCCACCG TCTGCCCCTG 
481 GATGTTGCCT GTGCCCGCGG CTACCTGGAT AAGGAAACCA TCACCGCCCT CACAGCGCCC 
541 AGAGATGACG CCCCCGAATT C 
1 RQLQLGERSV QEVAEVEAVR RALRGSGVIA GVWLEEARQK LSIYEALKKE 
51 LLQPEAAVAL LEAQAGTGHV IDPATSARVT VDEAVRAGLV GPELHEKLLS 
101 AEKAVTGYKD PYSGESVSLF QALKKGLIPR EQGLRLLDAQ LSTGGIVDPS 
151 KSHRLPLDVA CARGYLDKET ITALTAPRDD A 
500 
3 3 
2 2 
1 1 
-1 
-2 
-3 
500 
Figure 28. Nucleotide Sequence and ORF Map of a cDNA (0.45 kb insert) Encoding 
Bovine QPs2 and Deduced Amino Acid Sequence of Possi"ble ORF. 
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1 GAATTCGGGG GGCTGTCCGC ATGAAGTTAA GTGCCGTTAA AGATGTTGTG CGTGGCAAAA 
61 ATGTTGTCTT GGTGGATGAT TCAATTGTTC GTGGGACAAC CTCAATGTTT ATTGTACGGA 
121 TGTTAAAAGA AGCCGGCGCC AAGTCAGTGC ATGTGCGTAT TGCCAGTCCA GTCTTTAAAT 
181 TCCCATCATT TTATGGGATT GATATGCAAA CCACTGCTGA ATTAATGGGT GCTAATAATA 
241 CGCTAGATGA GATGCGCGAC AAGATTGAGG CGGATTCGCT TGGTTTCTTG ACTGTCGATG 
301 CGTTAGTCAA GGCGATTGAT TTACCCTATG ATGGTGAAGG CACAGGTCTG ACAACGGCGT 
361 ACTTTGATGG TCACTATCCA AGTCCAATCT ATGATTATGA AGACAGTCTA GCTGACTTTG 
421 TGGCAACGGG TGCGGTAGAC TTTACTGCTG AACCAACGAC CACCTATCAT CCCCGCCAAG 
481 TCGCTTCGTT ACGCAACGAA GAAATCATGG CTGATGGGAC GATCCATTTA GATTCACAAA 
541 CAATTCAGGG AGTAGAAGT 
560 ATG ACC GAA CAA AAC GCT TAT CAG CAA GCC GGC GTC GAC ATT AAA GCC GGT 
1 M T E Q N A y Q Q A G V D I K A G 
611 GAA GAA GCC GTC GAA TTG ATG AAA GAT GCG GTC GCT GAT ACG TAT AAT GCA 
18 E E A V E L M K D A V A D T y N A 
662 CAA GTT TTG GAT GGC TTA GGC GGC TTT GGG GCA GCT TTT GCT TTA GGT AAT 
35 Q V L D G L G G F G A A F A L G N 
713 CAG TAC CAA AAC CCT GTC TTG GTA TCG GGT GCT GAT GGT GTC GGG ACA AAG 
52 Q y Q N p V L V s G A D G V G T K 
764 TTG TTA CTA GCG ATT GCG GCT GAT AAA CAC GAT ACG ATT GGA CAA CAT CTT 
69 L L L A I A A D K H D T I G Q H L 
815 GTG GCG ATG GTG GCT AAC GAT ATT TTG GCA CAA GGG CCA AGC CGG CAT TTA 
86 V A M V A N D I L A Q G p s R H L 
866 TGT TGG ATT ATC TTG CCG TGG ATA AGA TGC GAC CAG CAG TCG TGG CAG AAA 
103 C w I I L p w I R C D Q Q s w Q K 
917 TTG TCA CGG GTG TGG CCA AGG CTG CCA AAG CTT CAG GGA TGG CGT TAA 
120 L s R V w p R L p K L Q G w R * 
965 TTGGTGGTGA AAGTGCAGAA TTACCAGGTC TTTATGCACC TAAGCACTAT GATTTGGCGG 
1925 CATTTGCTGT TGGTGTGGCT GAGCAAGACC AACTCTTAAA TCCTAAAAAC GTGGCGGTTG 
1085 GCGATGTTTT GATTGGTTTG CCATCTTCTG GAATTC 
500 1000 
3 3 
2 2 
1 1 
-1 
-1 
-2 
-2 
-3 
-3 
500 1000 
Figure 29. Nucleotide Sequence and ORF Map of a cDNA ( 1.1 kb insert) Encoding 
Bovine QPs2 and Deduced Amino Acid Sequence of Possible ORF. 
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partial ORF which codes 110 amino acids. The 0.85 kb insert shows one reasonable ORF 
which codes 99 amino acids to give QPs2 molecular weight of 10,120 Da. The 0.65 kb 
insert does not give any reasonable ORF, but the possibility of partial clone can not be 
excluded. The 0.45 kb insert, also, generates one full reading frame without any start or 
stop codon. The 1.1 kb insert shows a reasonable ORF which codes 134 amino acids to 
give QPs2 molecular weight of 14,320 Da. The possibility that a presequence exists may 
reduce the size of the true mature protein. 
QPs2 is a highly hydrophobic protein and believed to have transmembrane 
helix( ces) in its structure. Possibility for transmembrane helix formation and 
hydrophobicity of the protein could be partly examined by hydropathy plot of its amino 
acid sequence. The hydropathy plots of the five possible ORF are shown in Figure 30. 
The first ORF of 0.9kb insert yields a relatively hydrophilic protein with a small 
hydrophobic portion at COOR-terminus and the partial ORF of0.9kb insert gives QPs2 
two possible transmembrane helices. The ORF of 0.85kb insert allows QPs2 to have one 
hydrophobic part at the NHi-terminus and the 0.45kb insert produces a large protein 
without any possible transmembrane helix. The ORF of 1.1kb insert yields four QPs2 
hydrophobic portions with posSible helices structure. 
However, the amino acid sequence of the ORF in 0.85 kb insert was found to have 
weak similarity to fibrinogen, 0.45 kb insert 60% identity to rat Plectin, and 1.1 kb insert 
71 % identity to chicken 5-aminoimidazole ribotide synthase according to BLASTp 
searches. Therefore, the possibility of these three polypeptides to represent QPs2 may be 
ruled out. 
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Figure 30. Hydropathy plots of Five Possible QPs2 Sequences: (a), the first ORF of 
0.9kb insert; (b), the partial ORF of0.9kb insert; (c), the full region of 
0.45kb insert; (d), the ORF of0.85kb insert; and (e) the ORF of 1.1kb 
insert. 
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Confirmation of 0Ps2 cONA Clone 
Although we have all five posSI"ble cONA inserts for QPs2 sequenced, at present , 
no conclusion can be made because confirmation of QPs2 cONA clone met with 
experimental difficuhy. Several confirmation methods have been tried, but failed. 
These are: determination of the partial NH2-terminal sequence ofQPs2 either by 
microsequencing of the protein blotted on a PVDF membrane or by regular NHrterminal 
sequencing. Since SQR was used as a starting material for isolation of QPs2, a blue-
native gel electrophoretic step ( 14) was introduced to further purify the SQR 
The blue gel containing SQR was sliced and subjected to high resolution SOS-PAGE. 
Pure QPs2 blotted on a PVDF membrane or eluted from gel slices of SOS-PAGE of SQR 
was used for NH2-terminal amino acid sequence analysis. 
All the NH2-terminal amino acid sequence obtained showed the similar results with 
two heterogeneous sequences (Fig. 31). SOS-PAGE ofSQR, sometimes, showed two 
bands with similar sizes on the QPs2 position. These two bands reacted with anti-QPs2 
with equal intensity. The observation ofheterogeneous NH2-terminal amino acid 
sequences on QPs2 preparation and of two bands on SOS-PAGE can be explained as 
follows: (a) QPs2 preparation has the other impurity with similar size and amount; 
(b) these two NH2-terminal amino acid sequences obtained may originate from two other 
contaminants and the NH2-terminus ofQPs2 is modified post-translationally; or (c) some 
of QPs2 has been degraded during purification. It should be noted that the partial NH2-
terminal sequences observed in QPs2 preparation do not match with any of the NHr 
(A) QPs2 isolated from PVDF membrane of SQR obtained form calcium phosphate-
cellulose column chromatography · 
primary: 
secondary: 
Ser Pro Ser Lys Glu Ala ? 
Ile Gly Leu Tor 
Leu 
(B) QPs2 isolated from PVDF membrane of SQR obtained by blue native SOS-PAGE 
after calcium phosphate-cellulose column chromatography 
primary: 
secondary: 
Ser Pro Ser ? 
Ile Gly Leu 
Ala 
(C) QPs2 isolated from the gel slices of SOS-PAGE of SQR obtained by blue native 
SOS-PAGE after calcium phosphate-cellulose column chromatography 
primary: 
secondary: 
Gly 
Ile 
His 
Pro 
Ser 
Leu 
His 
Lys 
Ala 
Pro 
Ala 
His 
Figure 31. The Partial NH2-Amino Acid Sequence Analysis ofQPs2. 
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terminal amino acid sequences of QCR subunits, indicating that SQR preparation is not 
contaminated with QCR 
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A great effort has also been directed to confirm the isolated cDNA clones by 
internal peptide sequence of QPs2. Pure QPs2 obtained by the descn"bed method is highly 
aggregated and resistant to protease digestion. We have tried to subject the protein to 
reductive carboxymethylation before being digested by trypsin or chymotrypsin. When the 
digested, soluble fraction of the sample was applied onto Synchropak RP-8 column (0.46 
x 25 cm) using a gradient formed from 0.1 % tri:fluoroacetic acid and 90 % acetonitrile 
containing 0.1 % trifluoroacetic acid with a flow rate of 1 ml/min, several hydrophilic 
peptide peaks were revealed. However, their peptide sequences do not match with any of 
the obtained QPs2 sequences deduced from nucleotide sequencings. It is highly possible 
that these peptides are contaminants and the QPs2 protein was totally unsusceptible to 
trypsin or chymotrypsin digestion. 
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SUMMARY 
The amino acid sequence of QPsl was revised by addding 8 amino acid residues, 
LGTTAKEE-, to the NH2-terminus of reported sequence. This revision was made 
through the success in obtaining the partial NHrterminal amino acid sequence of QPsl. 
The use ofpre-electrophoresed SDS-PAGE gel and inclusion ofO.l mM sodium 
thioglycolate in the running buffer prevented blockage of the NHrterminus during 
electrophoresis, thus make sequencing possible. The molecular weight ofQPsl is 15,149. 
The cDNA encoding QPsl is 1003 bp long with a partial open reading frame of 
492 bp which encoded a 140-amino acid mature protein and a 24-amino acid presequence. 
The presequence of QPsl has typical mitochondrial signal peptide sequence. It has a 
preponderance ofbasic (Arg and Lys) and hydroxylated (Ser and Thr) residues, and the 
lack of acidic residues (Glu and Asp) to pass the mitochondrial membrane 
posttranslationally. QPsl is more likely to be processed by a two-step cleavage showing 
the similar consensus sequence (RAHLS) without arginine on -2 upstream position. 
The identification of QPsl as the Q-binding protein in SQR is achieved by 
photoa:ffinity labeling technique using azido-Q derivatives. When succinate-free SQR was 
incubated with 3-azido-2-methyl-5-methoxy-6-(3, 7-dimethyl[3H]-octyl)-l,4-benzoquinone 
([3H]azido-Q) in the dark for 20 min at O °C and then subjected to illumination with a long 
wavelength UV light for 7 min at 0°C, 3 5% of SQR activity was inactivated and 
radioactivity was found predominantly in QPsl. Since the extent of SQR inactivation 
upon illumination correlated with the amount of radioactivity labeling on QPsl, the 
participation of QPsl in Q-binding of SQR is obvious. 
117 
The Q-binding domain in QPsl is identified by peptide sequencing of a tryptic 
[3H]azido-Q peptide. The [3H]azido-Q peptide was obtained by HPLC separation of the 
tryptic digested, carboxymethylated, [3H]azido-Q labeled QPsl. The [3H]azido-Q labeled 
QPsl was obtained from [3H]azido-Q labeled SQR by preparative SDS-PAGE followed 
by electrophoretic elution of QPsl protein from gel slice. The partial NH2-terminal 
sequence oftryptic [3H]azido-Q peptide are GLTISQL-, which corresponds to residues 
113-119 ofQPsl sequence. The Q-binding domain is most likely located in the sequence 
connecting transmembrane helices 2 and 3. 
QPsl has been successfully expressed in E. coli DH5a cells as a GST fusion 
protein using a constructed QPsl expression vector, pGEX/QPsl. Production of 
recombinant GST-QPsl fusion protein in E. coli DH5 a cells harboring pGEX/QPsl 
plasmid is temperature, induction time, and growth media dependent. Maximum 
production of GST-QPsl fusion protein, which accounts for 10.2 % of total cellular 
protein, was obtained when cells were grown for 3 hrs at 27 °C in enriched medium 
containing 440 mM sorbitol and 2.5 mM betaine after addition ofIPTG. About 40 % of 
the total recombinant GST-QPsl fusion protein produced are in the soluble form; the rest 
are in inclusion body precicipates. The GST-QPsl fusion protein in inclusion body 
precipiate can be solubilized by 8 M urea treatment followed by dialysis. The recombinant 
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soluble GST-QPsl fusion either produced in cell-free extract or solubilized from inclusion 
body precipitates can be purified to homogeneity with a apparent molecular weight of 41 
kDa by a glutathione agarose gel column chromatography. 
Although QPsl has been believed to be cytochrome bs6o and the heme is thought 
to be ligated to the protein moiety by two conserved histidines located on the surface of 
the membrane, the recombinant GST-QPsl fusion protein contains little cytochrome bs6o 
heme moiety. Cytochrome bs6o could be reconstituted by addition ofhemin chloride in 
DMSO to isolated soluble recombinant GST-QPsl fusion protein. Maximum 
incorporation ofheme to the isolated GST-QPsl fusion was less than 0.5 mole ofheme 
per mole protein which corresponded to the purity of the isolated protein. The 
cytochrome bs6o heme in recombinant heme-reconstituted GST-QPsl was reactive to 
carbon monoxide. 
The heme-reconstituted recombinant QPsl was obtained from reconstituted 
recombinant GST-QPsl by thrombin treatment at room temperature for 1hr in the 
presence of0.01% n-dodecylmaltoside followed by removing GST and uncleaved GST-
QPsl fusion protein from the sample by Superose-12 (Pharmacia) gel filtration. Purified 
recombinant heme-containing QPsl is highly aggregated with an apparent molecular 
weight of over one million in 50 mM Tris-Cl, pH 8.0, containing 150 mM sodium chloride 
and 0.01 % dodecylmaltoside. This result indicates that the two histidines involved in 
ligation of heme exists in QPsl. 
Possible cDNA clones encoding QPs2 have been obtained by immunologically 
screening of the beef heart cDNA library in A.gt 11 with antibodies against QPs2. 
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Antibodies against QPs2 were raised in rabbits and purified. Purified antibodies against 
QPs2 have high titer as detemined by ELISA and are immunologically specific to 
mitochondrial QPs2 as determined by W estem Blot. Five clones with highest signal 
intensity were isolated, purified, and sequenced. However, confirmation of cDNA clone 
for QPs2 has met with difficulty due to the inability to obtain the NHrterminal partial 
amino acid sequence or internal peptide sequences of QPs2. 
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